,index,gene,pagerank_score,source_disease,ensembl_gene_id,druggability_tier,hgnc_names,chr_b37,start_b37,end_b37,strand,description,no_of_gwas_regions,small_mol_druggable,bio_druggable,adme_gene
0,0,FYN,0.0278157347334341,PD,ENSG00000010810,Tier 1,FYN,6,111981535.0,112194655.0,-1.0,"FYN oncogene related to SRC, FGR, YES [Source:HGNC Symbol;Acc:4037]",1.0,1.0,0.6,0.6
0,0,FYN,0.0278157347334341,Schizophrenia,ENSG00000010810,Tier 1,FYN,6,111981535.0,112194655.0,-1.0,"FYN oncogene related to SRC, FGR, YES [Source:HGNC Symbol;Acc:4037]",1.0,1.0,0.6,0.6
1,1,TGFB1,0.0188289451068194,MigraineDisorder,ENSG00000105329,Tier 1,TGFB1,19,41807492.0,41859816.0,-1.0,"transforming growth factor, beta 1 [Source:HGNC Symbol;Acc:11766]",1.0,1.0,1.0,0.6
2,2,MAPK3,0.0111159344940238,MS,ENSG00000102882,Tier 1,MAPK3,16,30125426.0,30134827.0,-1.0,mitogen-activated protein kinase 3 [Source:HGNC Symbol;Acc:6877],1.0,1.0,0.6,0.6
3,3,IL2,0.0106041573169802,BipolarDisorder,ENSG00000109471,Tier 1,IL2,4,123372625.0,123377880.0,-1.0,interleukin 2 [Source:HGNC Symbol;Acc:6001],9.0,0.6,1.0,0.6
3,3,IL2,0.0106041573169802,UnipolarDepression,ENSG00000109471,Tier 1,IL2,4,123372625.0,123377880.0,-1.0,interleukin 2 [Source:HGNC Symbol;Acc:6001],9.0,0.6,1.0,0.6
4,4,MAPK1,0.0097955187097841,MS,ENSG00000100030,Tier 1,MAPK1,22,22108789.0,22221970.0,-1.0,mitogen-activated protein kinase 1 [Source:HGNC Symbol;Acc:6871],1.0,1.0,0.6,0.6
5,5,STAT3,0.0094196205282766,MS,ENSG00000168610,Tier 1,STAT3,17,40465342.0,40540586.0,-1.0,signal transducer and activator of transcription 3 (acute-phase response factor) [Source:HGNC Symbol;Acc:11364],6.0,1.0,1.0,0.6
6,6,TYK2,0.0084978572062085,MS,ENSG00000105397,Tier 1,TYK2,19,10461209.0,10491352.0,-1.0,tyrosine kinase 2 [Source:HGNC Symbol;Acc:12440],7.0,1.0,0.6,0.6
7,7,HGF,0.0079147371489736,AD,ENSG00000019991,Tier 1,HGF,7,81328322.0,81399754.0,-1.0,hepatocyte growth factor (hepapoietin A; scatter factor) [Source:HGNC Symbol;Acc:4893],0.0,1.0,1.0,0.6
8,8,TNFRSF1A,0.0069891311275429,MS,ENSG00000067182,Tier 1,TNFRSF1A,12,6437923.0,6451280.0,-1.0,"tumor necrosis factor receptor superfamily, member 1A [Source:HGNC Symbol;Acc:11916]",3.0,1.0,1.0,0.6
9,9,FGFR3,0.006757796371956,PartialEpilepsy,ENSG00000068078,Tier 1,FGFR3,4,1795034.0,1810599.0,1.0,fibroblast growth factor receptor 3 [Source:HGNC Symbol;Acc:3690],0.0,1.0,1.0,0.6
10,10,CXCR4,0.0060889170128677,MS,ENSG00000121966,Tier 1,CXCR4,2,136871919.0,136875735.0,-1.0,chemokine (C-X-C motif) receptor 4 [Source:HGNC Symbol;Acc:2561],0.0,1.0,1.0,0.6
11,11,CCR4,0.0053842596657917,MS,ENSG00000183813,Tier 1,CCR4,3,32993066.0,32997841.0,1.0,chemokine (C-C motif) receptor 4 [Source:HGNC Symbol;Acc:1605],1.0,1.0,1.0,0.6
12,12,PDGFRB,0.0053119532755269,PD,ENSG00000113721,Tier 1,PDGFRB,5,149493400.0,149535435.0,-1.0,"platelet-derived growth factor receptor, beta polypeptide [Source:HGNC Symbol;Acc:8804]",0.0,1.0,1.0,0.6
13,13,ERBB2,0.0052879237738704,BipolarDisorder,ENSG00000141736,Tier 1,ERBB2,17,37844167.0,37886679.0,1.0,v-erb-b2 avian erythroblastic leukemia viral oncogene homolog 2 [Source:HGNC Symbol;Acc:3430],3.0,1.0,1.0,0.6
14,14,CXCR5,0.0050132709125612,MS,ENSG00000160683,Tier 1,CXCR5,11,118754475.0,118768508.0,1.0,chemokine (C-X-C motif) receptor 5 [Source:HGNC Symbol;Acc:1060],2.0,1.0,1.0,0.6
16,16,FGFR1,0.0045494649835004,BipolarDisorder,ENSG00000077782,Tier 1,FGFR1,8,38268656.0,38326352.0,-1.0,fibroblast growth factor receptor 1 [Source:HGNC Symbol;Acc:3688],1.0,1.0,1.0,0.6
16,16,FGFR1,0.0045494649835004,Schizophrenia,ENSG00000077782,Tier 1,FGFR1,8,38268656.0,38326352.0,-1.0,fibroblast growth factor receptor 1 [Source:HGNC Symbol;Acc:3688],1.0,1.0,1.0,0.6
17,17,LRP1,0.0045238104538683,MigraineDisorder,ENSG00000123384,Tier 3A,LRP1,12,57522276.0,57607134.0,1.0,low density lipoprotein receptor-related protein 1 [Source:HGNC Symbol;Acc:6692],7.0,0.6,1.0,0.6
17,17,LRP1,0.0045238104538683,MigraineWithAura,ENSG00000123384,Tier 3A,LRP1,12,57522276.0,57607134.0,1.0,low density lipoprotein receptor-related protein 1 [Source:HGNC Symbol;Acc:6692],7.0,0.6,1.0,0.6
17,17,LRP1,0.0045238104538683,Schizophrenia,ENSG00000123384,Tier 3A,LRP1,12,57522276.0,57607134.0,1.0,low density lipoprotein receptor-related protein 1 [Source:HGNC Symbol;Acc:6692],7.0,0.6,1.0,0.6
18,18,GPR20,0.0043609367048811,AnorexiaNervosa,ENSG00000204882,Tier 3B,GPR20,8,142366600.0,142377367.0,-1.0,G protein-coupled receptor 20 [Source:HGNC Symbol;Acc:4475],0.0,1.0,1.0,0.6
18,18,GPR20,0.0043609367048811,BipolarDisorder,ENSG00000204882,Tier 3B,GPR20,8,142366600.0,142377367.0,-1.0,G protein-coupled receptor 20 [Source:HGNC Symbol;Acc:4475],0.0,1.0,1.0,0.6
18,18,GPR20,0.0043609367048811,OCD,ENSG00000204882,Tier 3B,GPR20,8,142366600.0,142377367.0,-1.0,G protein-coupled receptor 20 [Source:HGNC Symbol;Acc:4475],0.0,1.0,1.0,0.6
18,18,GPR20,0.0043609367048811,Schizophrenia,ENSG00000204882,Tier 3B,GPR20,8,142366600.0,142377367.0,-1.0,G protein-coupled receptor 20 [Source:HGNC Symbol;Acc:4475],0.0,1.0,1.0,0.6
18,18,GPR20,0.0043609367048811,TouretteSyndrome,ENSG00000204882,Tier 3B,GPR20,8,142366600.0,142377367.0,-1.0,G protein-coupled receptor 20 [Source:HGNC Symbol;Acc:4475],0.0,1.0,1.0,0.6
18,18,GPR20,0.0043609367048811,UnipolarDepression,ENSG00000204882,Tier 3B,GPR20,8,142366600.0,142377367.0,-1.0,G protein-coupled receptor 20 [Source:HGNC Symbol;Acc:4475],0.0,1.0,1.0,0.6
19,19,CALCA,0.0042876682790045,MigraineDisorder,ENSG00000110680,Tier 1,CALCA,11,14988214.0,14993900.0,-1.0,calcitonin-related polypeptide alpha [Source:HGNC Symbol;Acc:1437],0.0,1.0,1.0,0.6
20,20,JAK1,0.0041696181435364,MS,ENSG00000162434,Tier 1,JAK1,1,65298912.0,65432187.0,-1.0,Janus kinase 1 [Source:HGNC Symbol;Acc:6190],0.0,1.0,0.6,0.6
21,21,ITGB5,0.0041303280141554,MigraineDisorder,ENSG00000082781,Tier 1,ITGB5,3,124480795.0,124620265.0,-1.0,"integrin, beta 5 [Source:HGNC Symbol;Acc:6160]",0.0,1.0,1.0,0.6
22,22,NGF,0.0041244463776995,MigraineDisorder,ENSG00000134259,Tier 1,NGF,1,115828539.0,115880857.0,-1.0,nerve growth factor (beta polypeptide) [Source:HGNC Symbol;Acc:7808],0.0,1.0,1.0,0.6
23,23,BMPR1B,0.0040763545632542,Schizophrenia,ENSG00000138696,Tier 1,BMPR1B,4,95679119.0,96079599.0,1.0,"bone morphogenetic protein receptor, type IB [Source:HGNC Symbol;Acc:1077]",0.0,1.0,1.0,0.6
24,24,SNCA,0.0040433868746642,LBD,ENSG00000145335,Tier 2,SNCA,4,90645250.0,90759466.0,-1.0,"synuclein, alpha (non A4 component of amyloid precursor) [Source:HGNC Symbol;Acc:11138]",13.0,1.0,1.0,0.6
24,24,SNCA,0.0040433868746642,PD,ENSG00000145335,Tier 2,SNCA,4,90645250.0,90759466.0,-1.0,"synuclein, alpha (non A4 component of amyloid precursor) [Source:HGNC Symbol;Acc:11138]",13.0,1.0,1.0,0.6
25,25,ACVR2A,0.0040367952273751,NeuroticDisorder,ENSG00000121989,Tier 2,ACVR2A,2,148602086.0,148688393.0,1.0,"activin A receptor, type IIA [Source:HGNC Symbol;Acc:173]",1.0,1.0,0.6,0.6
25,25,ACVR2A,0.0040367952273751,UnipolarDepression,ENSG00000121989,Tier 2,ACVR2A,2,148602086.0,148688393.0,1.0,"activin A receptor, type IIA [Source:HGNC Symbol;Acc:173]",1.0,1.0,0.6,0.6
26,26,NOS3,0.0039465413749804,AD,ENSG00000164867,Tier 1,NOS3,7,150688083.0,150711676.0,1.0,nitric oxide synthase 3 (endothelial cell) [Source:HGNC Symbol;Acc:7876],0.0,1.0,0.6,1.0
27,27,IFNAR1,0.0039085286444,NarcolepsyCataplexy,ENSG00000142166,Tier 1,IFNAR1,21,34696734.0,34732168.0,1.0,"interferon (alpha, beta and omega) receptor 1 [Source:HGNC Symbol;Acc:5432]",1.0,0.6,1.0,0.6
27,27,IFNAR1,0.0039085286444,Narcolepsy,ENSG00000142166,Tier 1,IFNAR1,21,34696734.0,34732168.0,1.0,"interferon (alpha, beta and omega) receptor 1 [Source:HGNC Symbol;Acc:5432]",1.0,0.6,1.0,0.6
28,28,DDR1,0.0038091394859798,Schizophrenia,ENSG00000204580,Tier 1,DDR1,6,30844198.0,30867933.0,1.0,discoidin domain receptor tyrosine kinase 1 [Source:HGNC Symbol;Acc:2730],19.0,1.0,1.0,0.6
29,29,TLR4,0.0037795203381325,NeuroticDisorder,ENSG00000136869,Tier 2,TLR4,9,120466610.0,120479149.0,1.0,toll-like receptor 4 [Source:HGNC Symbol;Acc:11850],0.0,1.0,1.0,0.6
29,29,TLR4,0.0037795203381325,UnipolarDepression,ENSG00000136869,Tier 2,TLR4,9,120466610.0,120479149.0,1.0,toll-like receptor 4 [Source:HGNC Symbol;Acc:11850],0.0,1.0,1.0,0.6
30,30,PDGFD,0.0037047830156556,MigraineDisorder,ENSG00000170962,Tier 3A,PDGFD,11,103777914.0,104035107.0,-1.0,platelet derived growth factor D [Source:HGNC Symbol;Acc:30620],0.0,0.6,1.0,0.6
31,31,BMP2,0.0036904101787716,UnipolarDepression,ENSG00000125845,Tier 3A,BMP2,20,6748311.0,6760927.0,1.0,bone morphogenetic protein 2 [Source:HGNC Symbol;Acc:1069],1.0,0.6,1.0,0.6
32,32,VEGFC,0.0036524543254516,BrainAneurysm,ENSG00000150630,Tier 3B,VEGFC,4,177604689.0,177713881.0,-1.0,vascular endothelial growth factor C [Source:HGNC Symbol;Acc:12682],0.0,0.6,1.0,0.6
33,33,IL6R,0.003636858780481,AD,ENSG00000160712,Tier 1,IL6R,1,154377669.0,154441926.0,1.0,interleukin 6 receptor [Source:HGNC Symbol;Acc:6019],9.0,0.6,1.0,0.6
34,34,LAMB3,0.0036127603411362,ALS,ENSG00000196878,Tier 1,LAMB3,1,209788215.0,209825811.0,-1.0,"laminin, beta 3 [Source:HGNC Symbol;Acc:6490]",0.0,0.6,1.0,0.6
35,35,RELN,0.0034178695480503,PartialEpilepsy,ENSG00000189056,Tier 3A,RELN,7,103112231.0,103629963.0,-1.0,reelin [Source:HGNC Symbol;Acc:9957],1.0,0.6,1.0,0.6
36,36,CD80,0.0033823952036712,MS,ENSG00000121594,Tier 1,CD80,3,119243140.0,119278449.0,-1.0,CD80 molecule [Source:HGNC Symbol;Acc:1700],6.0,0.6,1.0,0.6
37,37,ITGA9,0.0033311949025251,ALS,ENSG00000144668,Tier 3A,ITGA9,3,37493606.0,37865005.0,1.0,"integrin, alpha 9 [Source:HGNC Symbol;Acc:6145]",3.0,0.6,1.0,0.6
38,38,NRP1,0.0033238742984071,MigraineDisorder,ENSG00000099250,Tier 1,NRP1,10,33466420.0,33625190.0,-1.0,neuropilin 1 [Source:HGNC Symbol;Acc:8004],0.0,0.6,1.0,0.6
39,39,DPP4,0.0032925642109464,Schizophrenia,ENSG00000197635,Tier 1,DPP4,2,162848751.0,162931052.0,-1.0,dipeptidyl-peptidase 4 [Source:HGNC Symbol;Acc:3009],2.0,1.0,1.0,0.6
41,41,EFNA5,0.0032340806125074,BipolarDisorder,ENSG00000184349,Tier 3A,EFNA5,5,106712590.0,107006596.0,-1.0,ephrin-A5 [Source:HGNC Symbol;Acc:3225],0.0,0.6,1.0,0.6
41,41,EFNA5,0.0032340806125074,Schizophrenia,ENSG00000184349,Tier 3A,EFNA5,5,106712590.0,107006596.0,-1.0,ephrin-A5 [Source:HGNC Symbol;Acc:3225],0.0,0.6,1.0,0.6
41,41,EFNA5,0.0032340806125074,UnipolarDepression,ENSG00000184349,Tier 3A,EFNA5,5,106712590.0,107006596.0,-1.0,ephrin-A5 [Source:HGNC Symbol;Acc:3225],0.0,0.6,1.0,0.6
42,42,IL12B,0.0031370666717203,MS,ENSG00000113302,Tier 1,IL12B,5,158741791.0,158757895.0,-1.0,"interleukin 12B (natural killer cell stimulatory factor 2, cytotoxic lymphocyte maturation factor 2, p40) [Source:HGNC Symbol;Acc:5970]",5.0,0.6,1.0,0.6
42,42,IL12B,0.0031370666717203,UnipolarDepression,ENSG00000113302,Tier 1,IL12B,5,158741791.0,158757895.0,-1.0,"interleukin 12B (natural killer cell stimulatory factor 2, cytotoxic lymphocyte maturation factor 2, p40) [Source:HGNC Symbol;Acc:5970]",5.0,0.6,1.0,0.6
43,43,ITGA2B,0.0030567295095783,AD,ENSG00000005961,Tier 1,ITGA2B,17,42449548.0,42466873.0,-1.0,"integrin, alpha 2b (platelet glycoprotein IIb of IIb/IIIa complex, antigen CD41) [Source:HGNC Symbol;Acc:6138]",1.0,1.0,1.0,0.6
43,43,ITGA2B,0.0030567295095783,PD,ENSG00000005961,Tier 1,ITGA2B,17,42449548.0,42466873.0,-1.0,"integrin, alpha 2b (platelet glycoprotein IIb of IIb/IIIa complex, antigen CD41) [Source:HGNC Symbol;Acc:6138]",1.0,1.0,1.0,0.6
44,44,NRXN1,0.0030310841142123,Schizophrenia,ENSG00000179915,Tier 3A,NRXN1,2,50145643.0,51259674.0,-1.0,neurexin 1 [Source:HGNC Symbol;Acc:8008],0.0,0.6,1.0,0.6
44,44,NRXN1,0.0030310841142123,UnipolarDepression,ENSG00000179915,Tier 3A,NRXN1,2,50145643.0,51259674.0,-1.0,neurexin 1 [Source:HGNC Symbol;Acc:8008],0.0,0.6,1.0,0.6
46,46,ITGB7,0.0029941265902979,Schizophrenia,ENSG00000139626,Tier 1,ITGB7,12,53585102.0,53601091.0,-1.0,"integrin, beta 7 [Source:HGNC Symbol;Acc:6162]",0.0,1.0,1.0,0.6
47,47,ACKR1,0.0029345479455663,Schizophrenia,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05
48,48,ACVR1B,0.0029303309463226,MajorDepressiveDisorder,ENSG00000135503,Tier 1,ACVR1B,12,52345451.0,52390862.0,1.0,"activin A receptor, type IB [Source:HGNC Symbol;Acc:172]",0.0,1.0,0.6,0.6
49,49,WNT4,0.0029199617685012,Schizophrenia,ENSG00000162552,Tier 3A,WNT4,1,22443798.0,22470462.0,-1.0,"wingless-type MMTV integration site family, member 4 [Source:HGNC Symbol;Acc:12783]",11.0,0.6,1.0,0.6
50,50,SST,0.0029026584990198,MS,ENSG00000157005,Tier 1,SST,3,187386694.0,187388187.0,-1.0,somatostatin [Source:HGNC Symbol;Acc:11329],0.0,0.6,1.0,0.6
51,51,LEPR,0.0028239093382211,Schizophrenia,ENSG00000116678,Tier 3A,LEPR,1,65886248.0,66107242.0,1.0,leptin receptor [Source:HGNC Symbol;Acc:6554],8.0,0.6,1.0,0.6
52,52,ITGA8,0.0027798464433841,PD,ENSG00000077943,Tier 3A,ITGA8,10,15555948.0,15762124.0,-1.0,"integrin, alpha 8 [Source:HGNC Symbol;Acc:6144]",0.0,0.6,1.0,0.6
53,53,MDK,0.002758289272577,AnorexiaNervosa,ENSG00000110492,Tier 3A,MDK,11,46402306.0,46405375.0,1.0,midkine (neurite growth-promoting factor 2) [Source:HGNC Symbol;Acc:6972],0.0,0.6,1.0,0.6
53,53,MDK,0.002758289272577,BipolarDisorder,ENSG00000110492,Tier 3A,MDK,11,46402306.0,46405375.0,1.0,midkine (neurite growth-promoting factor 2) [Source:HGNC Symbol;Acc:6972],0.0,0.6,1.0,0.6
53,53,MDK,0.002758289272577,OCD,ENSG00000110492,Tier 3A,MDK,11,46402306.0,46405375.0,1.0,midkine (neurite growth-promoting factor 2) [Source:HGNC Symbol;Acc:6972],0.0,0.6,1.0,0.6
53,53,MDK,0.002758289272577,Schizophrenia,ENSG00000110492,Tier 3A,MDK,11,46402306.0,46405375.0,1.0,midkine (neurite growth-promoting factor 2) [Source:HGNC Symbol;Acc:6972],0.0,0.6,1.0,0.6
53,53,MDK,0.002758289272577,TouretteSyndrome,ENSG00000110492,Tier 3A,MDK,11,46402306.0,46405375.0,1.0,midkine (neurite growth-promoting factor 2) [Source:HGNC Symbol;Acc:6972],0.0,0.6,1.0,0.6
53,53,MDK,0.002758289272577,UnipolarDepression,ENSG00000110492,Tier 3A,MDK,11,46402306.0,46405375.0,1.0,midkine (neurite growth-promoting factor 2) [Source:HGNC Symbol;Acc:6972],0.0,0.6,1.0,0.6
54,54,APOB,0.0027560574708076,AD,ENSG00000084674,Tier 1,APOB,2,21224301.0,21266945.0,-1.0,apolipoprotein B [Source:HGNC Symbol;Acc:603],36.0,1.0,1.0,0.6
54,54,APOB,0.0027560574708076,BipolarDisorder,ENSG00000084674,Tier 1,APOB,2,21224301.0,21266945.0,-1.0,apolipoprotein B [Source:HGNC Symbol;Acc:603],36.0,1.0,1.0,0.6
56,56,IFNGR2,0.002672204559919,MS,ENSG00000159128,Tier 1,IFNGR2,21,34775202.0,34851655.0,1.0,interferon gamma receptor 2 (interferon gamma transducer 1) [Source:HGNC Symbol;Acc:5440],2.0,0.6,1.0,0.6
57,57,NECTIN2,0.0025991216446547,AD,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05
57,57,NECTIN2,0.0025991216446547,PD,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05
59,59,RPS6KB1,0.0025327630419323,MS,ENSG00000108443,Tier 1,RPS6KB1,17,57970447.0,58027925.0,1.0,"ribosomal protein S6 kinase, 70kDa, polypeptide 1 [Source:HGNC Symbol;Acc:10436]",2.0,1.0,0.6,0.6
60,60,CSF3,0.0024139980515216,BipolarDisorder,ENSG00000108342,Tier 3A,CSF3,17,38171614.0,38174066.0,1.0,colony stimulating factor 3 (granulocyte) [Source:HGNC Symbol;Acc:2438],8.0,0.6,1.0,0.6
61,61,ACKR2,0.0024048658586598,AD,ENSG00000144648,Tier 3B,ACKR2,3,42846244.0,42929466.0,1.0,atypical chemokine receptor 2 [Source:HGNC Symbol;Acc:1565],1.0,1.0,1.0,0.6
62,62,CRH,0.0023984003838208,PartialEpilepsy,ENSG00000147571,Tier 3B,CRH,8,67088620.0,67090960.0,-1.0,corticotropin releasing hormone [Source:HGNC Symbol;Acc:2355],0.0,0.6,1.0,0.6
63,63,IL7R,0.0023917276454822,MS,ENSG00000168685,Tier 3A,IL7R,5,35852797.0,35879705.0,1.0,interleukin 7 receptor [Source:HGNC Symbol;Acc:6024],4.0,0.6,1.0,0.6
64,64,IL10RB,0.0023032428672228,NarcolepsyCataplexy,ENSG00000243646,Tier 3B,IL10RB,21,34638663.0,34669539.0,1.0,"interleukin 10 receptor, beta [Source:HGNC Symbol;Acc:5965]",1.0,0.6,1.0,0.6
64,64,IL10RB,0.0023032428672228,Narcolepsy,ENSG00000243646,Tier 3B,IL10RB,21,34638663.0,34669539.0,1.0,"interleukin 10 receptor, beta [Source:HGNC Symbol;Acc:5965]",1.0,0.6,1.0,0.6
65,65,PLAU,0.0022978119540229,MS,ENSG00000122861,Tier 2,PLAU,10,75668935.0,75677255.0,1.0,"plasminogen activator, urokinase [Source:HGNC Symbol;Acc:9052]",1.0,1.0,1.0,0.6
66,66,APOE,0.0022884513671086,AD,ENSG00000130203,Tier 3A,APOE,19,45409011.0,45412650.0,1.0,apolipoprotein E [Source:HGNC Symbol;Acc:613],84.0,0.6,1.0,0.6
66,66,APOE,0.0022884513671086,LBD,ENSG00000130203,Tier 3A,APOE,19,45409011.0,45412650.0,1.0,apolipoprotein E [Source:HGNC Symbol;Acc:613],84.0,0.6,1.0,0.6
66,66,APOE,0.0022884513671086,PD,ENSG00000130203,Tier 3A,APOE,19,45409011.0,45412650.0,1.0,apolipoprotein E [Source:HGNC Symbol;Acc:613],84.0,0.6,1.0,0.6
67,67,GAL,0.0022416906832757,PartialEpilepsy,ENSG00000069482,Tier 3B,GAL,11,68451247.0,68458643.0,1.0,galanin/GMAP prepropeptide [Source:HGNC Symbol;Acc:4114],0.0,0.6,1.0,0.6
68,68,PTK2B,0.0022040103454285,AD,ENSG00000120899,Tier 1,PTK2B,8,27168999.0,27316903.0,1.0,protein tyrosine kinase 2 beta [Source:HGNC Symbol;Acc:9612],1.0,1.0,0.6,0.6
69,69,HBEGF,0.0021914220637923,AD,ENSG00000113070,Tier 1,HBEGF,5,139712428.0,139726216.0,-1.0,heparin-binding EGF-like growth factor [Source:HGNC Symbol;Acc:3059],0.0,0.6,1.0,0.6
70,70,PTN,0.0021771545790303,AnorexiaNervosa,ENSG00000105894,Tier 3B,PTN,7,136912088.0,137028611.0,-1.0,pleiotrophin [Source:HGNC Symbol;Acc:9630],0.0,0.6,1.0,0.6
70,70,PTN,0.0021771545790303,BipolarDisorder,ENSG00000105894,Tier 3B,PTN,7,136912088.0,137028611.0,-1.0,pleiotrophin [Source:HGNC Symbol;Acc:9630],0.0,0.6,1.0,0.6
70,70,PTN,0.0021771545790303,OCD,ENSG00000105894,Tier 3B,PTN,7,136912088.0,137028611.0,-1.0,pleiotrophin [Source:HGNC Symbol;Acc:9630],0.0,0.6,1.0,0.6
70,70,PTN,0.0021771545790303,Schizophrenia,ENSG00000105894,Tier 3B,PTN,7,136912088.0,137028611.0,-1.0,pleiotrophin [Source:HGNC Symbol;Acc:9630],0.0,0.6,1.0,0.6
70,70,PTN,0.0021771545790303,TouretteSyndrome,ENSG00000105894,Tier 3B,PTN,7,136912088.0,137028611.0,-1.0,pleiotrophin [Source:HGNC Symbol;Acc:9630],0.0,0.6,1.0,0.6
70,70,PTN,0.0021771545790303,UnipolarDepression,ENSG00000105894,Tier 3B,PTN,7,136912088.0,137028611.0,-1.0,pleiotrophin [Source:HGNC Symbol;Acc:9630],0.0,0.6,1.0,0.6
73,73,PILRA,0.0021227353702093,AD,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05
76,76,ESR1,0.0020821111974747,UnipolarDepression,ENSG00000091831,Tier 1,ESR1,6,151977826.0,152450754.0,1.0,estrogen receptor 1 [Source:HGNC Symbol;Acc:3467],14.0,1.0,0.6,0.6
78,78,ERBB4,0.0020527555082805,ALS,ENSG00000178568,Tier 1,ERBB4,2,212240446.0,213403565.0,-1.0,v-erb-b2 avian erythroblastic leukemia viral oncogene homolog 4 [Source:HGNC Symbol;Acc:3432],1.0,1.0,1.0,0.6
78,78,ERBB4,0.0020527555082805,FrontotemporalDementia,ENSG00000178568,Tier 1,ERBB4,2,212240446.0,213403565.0,-1.0,v-erb-b2 avian erythroblastic leukemia viral oncogene homolog 4 [Source:HGNC Symbol;Acc:3432],1.0,1.0,1.0,0.6
78,78,ERBB4,0.0020527555082805,MajorDepressiveDisorder,ENSG00000178568,Tier 1,ERBB4,2,212240446.0,213403565.0,-1.0,v-erb-b2 avian erythroblastic leukemia viral oncogene homolog 4 [Source:HGNC Symbol;Acc:3432],1.0,1.0,1.0,0.6
78,78,ERBB4,0.0020527555082805,UnipolarDepression,ENSG00000178568,Tier 1,ERBB4,2,212240446.0,213403565.0,-1.0,v-erb-b2 avian erythroblastic leukemia viral oncogene homolog 4 [Source:HGNC Symbol;Acc:3432],1.0,1.0,1.0,0.6
80,80,WNT7B,0.0020423188480565,BipolarDisorder,ENSG00000188064,Tier 3A,WNT7B,22,46316242.0,46373009.0,-1.0,"wingless-type MMTV integration site family, member 7B [Source:HGNC Symbol;Acc:12787]",0.0,0.6,1.0,0.6
80,80,WNT7B,0.0020423188480565,MajorDepressiveDisorder,ENSG00000188064,Tier 3A,WNT7B,22,46316242.0,46373009.0,-1.0,"wingless-type MMTV integration site family, member 7B [Source:HGNC Symbol;Acc:12787]",0.0,0.6,1.0,0.6
80,80,WNT7B,0.0020423188480565,Schizophrenia,ENSG00000188064,Tier 3A,WNT7B,22,46316242.0,46373009.0,-1.0,"wingless-type MMTV integration site family, member 7B [Source:HGNC Symbol;Acc:12787]",0.0,0.6,1.0,0.6
80,80,WNT7B,0.0020423188480565,UnipolarDepression,ENSG00000188064,Tier 3A,WNT7B,22,46316242.0,46373009.0,-1.0,"wingless-type MMTV integration site family, member 7B [Source:HGNC Symbol;Acc:12787]",0.0,0.6,1.0,0.6
81,81,WNT3,0.0020321959245986,PD,ENSG00000108379,Tier 2,WNT3,17,44839872.0,44910520.0,-1.0,"wingless-type MMTV integration site family, member 3 [Source:HGNC Symbol;Acc:12782]",13.0,1.0,1.0,0.6
81,81,WNT3,0.0020321959245986,Schizophrenia,ENSG00000108379,Tier 2,WNT3,17,44839872.0,44910520.0,-1.0,"wingless-type MMTV integration site family, member 3 [Source:HGNC Symbol;Acc:12782]",13.0,1.0,1.0,0.6
83,83,IL12A,0.0019457895891021,MS,ENSG00000168811,Tier 3A,IL12A,3,159706537.0,159713806.0,1.0,"interleukin 12A (natural killer cell stimulatory factor 1, cytotoxic lymphocyte maturation factor 1, p35) [Source:HGNC Symbol;Acc:5969]",2.0,0.6,1.0,0.6
86,86,WNT9B,0.0019247579021702,MS,ENSG00000158955,Tier 3A,WNT9B,17,44910567.0,44964096.0,1.0,"wingless-type MMTV integration site family, member 9B [Source:HGNC Symbol;Acc:12779]",0.0,0.6,1.0,0.6
86,86,WNT9B,0.0019247579021702,PD,ENSG00000158955,Tier 3A,WNT9B,17,44910567.0,44964096.0,1.0,"wingless-type MMTV integration site family, member 9B [Source:HGNC Symbol;Acc:12779]",0.0,0.6,1.0,0.6
87,87,CNTN1,0.0019111268713609,PD,ENSG00000018236,Tier 3A,CNTN1,12,41086244.0,41466220.0,1.0,contactin 1 [Source:HGNC Symbol;Acc:2171],1.0,0.6,1.0,0.6
88,88,FSTL5,0.00188720797584,BipolarDisorder,ENSG00000168843,Tier 3A,FSTL5,4,162305049.0,163085187.0,-1.0,follistatin-like 5 [Source:HGNC Symbol;Acc:21386],0.0,0.6,1.0,0.6
88,88,FSTL5,0.00188720797584,UnipolarDepression,ENSG00000168843,Tier 3A,FSTL5,4,162305049.0,163085187.0,-1.0,follistatin-like 5 [Source:HGNC Symbol;Acc:21386],0.0,0.6,1.0,0.6
89,89,ADO,0.0018730748735651,BipolarDisorder,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05
89,89,ADO,0.0018730748735651,MS,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05
89,89,ADO,0.0018730748735651,NarcolepsyCataplexy,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05
89,89,ADO,0.0018730748735651,Narcolepsy,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05
90,90,GFRA2,0.0018730748735651,FrontotemporalDementia,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05
91,91,STAT6,0.0018645097468887,MigraineDisorder,ENSG00000166888,Tier 2,STAT6,12,57489191.0,57525922.0,-1.0,"signal transducer and activator of transcription 6, interleukin-4 induced [Source:HGNC Symbol;Acc:11368]",8.0,1.0,0.6,0.6
91,91,STAT6,0.0018645097468887,MigraineWithAura,ENSG00000166888,Tier 2,STAT6,12,57489191.0,57525922.0,-1.0,"signal transducer and activator of transcription 6, interleukin-4 induced [Source:HGNC Symbol;Acc:11368]",8.0,1.0,0.6,0.6
91,91,STAT6,0.0018645097468887,Schizophrenia,ENSG00000166888,Tier 2,STAT6,12,57489191.0,57525922.0,-1.0,"signal transducer and activator of transcription 6, interleukin-4 induced [Source:HGNC Symbol;Acc:11368]",8.0,1.0,0.6,0.6
92,92,LCK,0.0018453497439253,MS,ENSG00000182866,Tier 1,LCK,1,32716840.0,32751766.0,1.0,lymphocyte-specific protein tyrosine kinase [Source:HGNC Symbol;Acc:6524],0.0,1.0,0.6,0.6
93,93,DCC,0.0018265507099591,AnorexiaNervosa,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05
93,93,DCC,0.0018265507099591,BipolarDisorder,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05
93,93,DCC,0.0018265507099591,MajorDepressiveDisorder,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05
93,93,DCC,0.0018265507099591,NeuroticDisorder,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05
93,93,DCC,0.0018265507099591,OCD,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05
93,93,DCC,0.0018265507099591,Schizophrenia,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05
93,93,DCC,0.0018265507099591,TouretteSyndrome,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05
93,93,DCC,0.0018265507099591,UnipolarDepression,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05
94,94,CD8B,0.0017934292543208,ProgressiveSupranuclearPalsy,ENSG00000172116,Tier 3A,CD8B,2,87042462.0,87089047.0,-1.0,CD8b molecule [Source:HGNC Symbol;Acc:1707],1.0,0.6,1.0,0.6
95,95,DKK1,0.0017785748685266,Schizophrenia,ENSG00000107984,Tier 1,DKK1,10,54074056.0,54077802.0,1.0,dickkopf WNT signaling pathway inhibitor 1 [Source:HGNC Symbol;Acc:2891],0.0,1.0,1.0,0.6
96,96,APP,0.0017689816407579,AD,ENSG00000142192,Tier 1,APP,21,27252861.0,27543446.0,-1.0,amyloid beta (A4) precursor protein [Source:HGNC Symbol;Acc:620],0.0,1.0,1.0,0.6
97,97,HP,0.0017417325921946,AnorexiaNervosa,ENSG00000257017,Tier 3A,HP,16,72088491.0,72094954.0,1.0,haptoglobin [Source:HGNC Symbol;Acc:5141],7.0,0.6,1.0,0.6
97,97,HP,0.0017417325921946,BipolarDisorder,ENSG00000257017,Tier 3A,HP,16,72088491.0,72094954.0,1.0,haptoglobin [Source:HGNC Symbol;Acc:5141],7.0,0.6,1.0,0.6
97,97,HP,0.0017417325921946,OCD,ENSG00000257017,Tier 3A,HP,16,72088491.0,72094954.0,1.0,haptoglobin [Source:HGNC Symbol;Acc:5141],7.0,0.6,1.0,0.6
97,97,HP,0.0017417325921946,Schizophrenia,ENSG00000257017,Tier 3A,HP,16,72088491.0,72094954.0,1.0,haptoglobin [Source:HGNC Symbol;Acc:5141],7.0,0.6,1.0,0.6
97,97,HP,0.0017417325921946,TouretteSyndrome,ENSG00000257017,Tier 3A,HP,16,72088491.0,72094954.0,1.0,haptoglobin [Source:HGNC Symbol;Acc:5141],7.0,0.6,1.0,0.6
97,97,HP,0.0017417325921946,UnipolarDepression,ENSG00000257017,Tier 3A,HP,16,72088491.0,72094954.0,1.0,haptoglobin [Source:HGNC Symbol;Acc:5141],7.0,0.6,1.0,0.6
98,98,NOTCH3,0.001733600418996,MigraineDisorder,ENSG00000074181,Tier 3B,NOTCH3,19,15270444.0,15311792.0,-1.0,notch 3 [Source:HGNC Symbol;Acc:7883],0.0,0.6,1.0,0.6
98,98,NOTCH3,0.001733600418996,MigraineWithAura,ENSG00000074181,Tier 3B,NOTCH3,19,15270444.0,15311792.0,-1.0,notch 3 [Source:HGNC Symbol;Acc:7883],0.0,0.6,1.0,0.6
100,100,IAPP,0.0017044455121994,ProgressiveSupranuclearPalsy,ENSG00000121351,Tier 1,IAPP,12,21507893.0,21532912.0,1.0,islet amyloid polypeptide [Source:HGNC Symbol;Acc:5329],0.0,0.6,1.0,1.0
101,101,FGF23,0.00168348567589,MigraineDisorder,ENSG00000118972,Tier 3B,FGF23,12,4477393.0,4488894.0,-1.0,fibroblast growth factor 23 [Source:HGNC Symbol;Acc:3680],0.0,0.6,1.0,0.6
102,102,FGF20,0.00168348567589,PD,ENSG00000078579,Tier 3B,FGF20,8,16849678.0,16859690.0,-1.0,fibroblast growth factor 20 [Source:HGNC Symbol;Acc:3677],0.0,0.6,1.0,0.6
109,109,BMP8A,0.0016356179669179,MigraineDisorder,ENSG00000183682,Tier 3A,BMP8A,1,39957318.0,39991607.0,1.0,bone morphogenetic protein 8a [Source:HGNC Symbol;Acc:21650],4.0,0.6,1.0,0.6
110,110,MAP3K14,0.0015797499672406,MS,ENSG00000006062,Tier 2,MAP3K14,17,43340488.0,43394414.0,-1.0,mitogen-activated protein kinase kinase kinase 14 [Source:HGNC Symbol;Acc:6853],0.0,1.0,0.6,0.6
112,112,FGF6,0.001573751365807,MigraineDisorder,ENSG00000111241,Tier 3B,FGF6,12,4537321.0,4554780.0,-1.0,fibroblast growth factor 6 [Source:HGNC Symbol;Acc:3684],0.0,0.6,1.0,0.6
113,113,CALCB,0.0015677461514887,MigraineDisorder,ENSG00000175868,Tier 3A,CALCB,11,14926543.0,15103888.0,1.0,calcitonin-related polypeptide beta [Source:HGNC Symbol;Acc:1438],4.0,0.6,1.0,0.6
116,116,PMCH,0.0015304213448598,RestlessLeg,ENSG00000183395,Tier 3B,PMCH,12,102590237.0,102591623.0,-1.0,pro-melanin-concentrating hormone [Source:HGNC Symbol;Acc:9109],3.0,0.6,1.0,0.6
117,117,NOTCH4,0.0015139947431411,MigraineDisorder,ENSG00000204301,Tier 3A,NOTCH4,6,32162620.0,32191844.0,-1.0,notch 4 [Source:HGNC Symbol;Acc:7884],61.0,0.6,1.0,0.6
117,117,NOTCH4,0.0015139947431411,Schizophrenia,ENSG00000204301,Tier 3A,NOTCH4,6,32162620.0,32191844.0,-1.0,notch 4 [Source:HGNC Symbol;Acc:7884],61.0,0.6,1.0,0.6
118,118,NMB,0.0015128475913572,AnorexiaNervosa,ENSG00000197696,Tier 3B,NMB,15,85198360.0,85201794.0,-1.0,neuromedin B [Source:HGNC Symbol;Acc:7842],1.0,0.6,1.0,0.6
118,118,NMB,0.0015128475913572,BipolarDisorder,ENSG00000197696,Tier 3B,NMB,15,85198360.0,85201794.0,-1.0,neuromedin B [Source:HGNC Symbol;Acc:7842],1.0,0.6,1.0,0.6
118,118,NMB,0.0015128475913572,OCD,ENSG00000197696,Tier 3B,NMB,15,85198360.0,85201794.0,-1.0,neuromedin B [Source:HGNC Symbol;Acc:7842],1.0,0.6,1.0,0.6
118,118,NMB,0.0015128475913572,Schizophrenia,ENSG00000197696,Tier 3B,NMB,15,85198360.0,85201794.0,-1.0,neuromedin B [Source:HGNC Symbol;Acc:7842],1.0,0.6,1.0,0.6
118,118,NMB,0.0015128475913572,TouretteSyndrome,ENSG00000197696,Tier 3B,NMB,15,85198360.0,85201794.0,-1.0,neuromedin B [Source:HGNC Symbol;Acc:7842],1.0,0.6,1.0,0.6
118,118,NMB,0.0015128475913572,UnipolarDepression,ENSG00000197696,Tier 3B,NMB,15,85198360.0,85201794.0,-1.0,neuromedin B [Source:HGNC Symbol;Acc:7842],1.0,0.6,1.0,0.6
120,120,PRKD1,0.0015085159054531,BipolarDisorder,ENSG00000184304,Tier 1,PRKD1,14,30045687.0,30661104.0,-1.0,protein kinase D1 [Source:HGNC Symbol;Acc:9407],2.0,1.0,0.6,0.6
120,120,PRKD1,0.0015085159054531,Schizophrenia,ENSG00000184304,Tier 1,PRKD1,14,30045687.0,30661104.0,-1.0,protein kinase D1 [Source:HGNC Symbol;Acc:9407],2.0,1.0,0.6,0.6
121,121,TNFSF14,0.0014952043926456,MS,ENSG00000125735,Tier 1,TNFSF14,19,6663148.0,6670599.0,-1.0,"tumor necrosis factor (ligand) superfamily, member 14 [Source:HGNC Symbol;Acc:11930]",1.0,0.6,1.0,0.6
124,124,SERPINF1,0.0014654286183778,AD,ENSG00000132386,Tier 3A,SERPINF1,17,1665253.0,1680868.0,1.0,"serpin peptidase inhibitor, clade F (alpha-2 antiplasmin, pigment epithelium derived factor), member 1 [Source:HGNC Symbol;Acc:8824]",0.0,0.6,1.0,0.6
126,126,FSHB,0.0014236891784204,MigraineDisorder,ENSG00000131808,Tier 3B,FSHB,11,30252563.0,30256808.0,1.0,"follicle stimulating hormone, beta polypeptide [Source:HGNC Symbol;Acc:3964]",1.0,0.6,1.0,0.6
126,126,FSHB,0.0014236891784204,Schizophrenia,ENSG00000131808,Tier 3B,FSHB,11,30252563.0,30256808.0,1.0,"follicle stimulating hormone, beta polypeptide [Source:HGNC Symbol;Acc:3964]",1.0,0.6,1.0,0.6
127,127,CSF3R,0.0014214493765917,AnorexiaNervosa,ENSG00000119535,Tier 1,CSF3R,1,36931644.0,36948879.0,-1.0,colony stimulating factor 3 receptor (granulocyte) [Source:HGNC Symbol;Acc:2439],0.0,0.6,1.0,0.6
127,127,CSF3R,0.0014214493765917,BipolarDisorder,ENSG00000119535,Tier 1,CSF3R,1,36931644.0,36948879.0,-1.0,colony stimulating factor 3 receptor (granulocyte) [Source:HGNC Symbol;Acc:2439],0.0,0.6,1.0,0.6
127,127,CSF3R,0.0014214493765917,MajorDepressiveDisorder,ENSG00000119535,Tier 1,CSF3R,1,36931644.0,36948879.0,-1.0,colony stimulating factor 3 receptor (granulocyte) [Source:HGNC Symbol;Acc:2439],0.0,0.6,1.0,0.6
127,127,CSF3R,0.0014214493765917,NeuroticDisorder,ENSG00000119535,Tier 1,CSF3R,1,36931644.0,36948879.0,-1.0,colony stimulating factor 3 receptor (granulocyte) [Source:HGNC Symbol;Acc:2439],0.0,0.6,1.0,0.6
127,127,CSF3R,0.0014214493765917,OCD,ENSG00000119535,Tier 1,CSF3R,1,36931644.0,36948879.0,-1.0,colony stimulating factor 3 receptor (granulocyte) [Source:HGNC Symbol;Acc:2439],0.0,0.6,1.0,0.6
127,127,CSF3R,0.0014214493765917,Schizophrenia,ENSG00000119535,Tier 1,CSF3R,1,36931644.0,36948879.0,-1.0,colony stimulating factor 3 receptor (granulocyte) [Source:HGNC Symbol;Acc:2439],0.0,0.6,1.0,0.6
127,127,CSF3R,0.0014214493765917,TouretteSyndrome,ENSG00000119535,Tier 1,CSF3R,1,36931644.0,36948879.0,-1.0,colony stimulating factor 3 receptor (granulocyte) [Source:HGNC Symbol;Acc:2439],0.0,0.6,1.0,0.6
127,127,CSF3R,0.0014214493765917,UnipolarDepression,ENSG00000119535,Tier 1,CSF3R,1,36931644.0,36948879.0,-1.0,colony stimulating factor 3 receptor (granulocyte) [Source:HGNC Symbol;Acc:2439],0.0,0.6,1.0,0.6
128,128,PDCD1,0.001415643514116,BrainAneurysm,ENSG00000188389,Tier 1,PDCD1,2,242792033.0,242801060.0,-1.0,programmed cell death 1 [Source:HGNC Symbol;Acc:8760],0.0,0.6,1.0,0.6
128,128,PDCD1,0.001415643514116,MS,ENSG00000188389,Tier 1,PDCD1,2,242792033.0,242801060.0,-1.0,programmed cell death 1 [Source:HGNC Symbol;Acc:8760],0.0,0.6,1.0,0.6
129,129,PTCH1,0.0014137475543724,NeuroticDisorder,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05
129,129,PTCH1,0.0014137475543724,UnipolarDepression,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05
132,132,CDH5,0.0013949267602478,AnorexiaNervosa,ENSG00000179776,Tier 3B,CDH5,16,66400533.0,66438686.0,1.0,"cadherin 5, type 2 (vascular endothelium) [Source:HGNC Symbol;Acc:1764]",0.0,0.6,1.0,0.6
132,132,CDH5,0.0013949267602478,BipolarDisorder,ENSG00000179776,Tier 3B,CDH5,16,66400533.0,66438686.0,1.0,"cadherin 5, type 2 (vascular endothelium) [Source:HGNC Symbol;Acc:1764]",0.0,0.6,1.0,0.6
132,132,CDH5,0.0013949267602478,OCD,ENSG00000179776,Tier 3B,CDH5,16,66400533.0,66438686.0,1.0,"cadherin 5, type 2 (vascular endothelium) [Source:HGNC Symbol;Acc:1764]",0.0,0.6,1.0,0.6
132,132,CDH5,0.0013949267602478,Schizophrenia,ENSG00000179776,Tier 3B,CDH5,16,66400533.0,66438686.0,1.0,"cadherin 5, type 2 (vascular endothelium) [Source:HGNC Symbol;Acc:1764]",0.0,0.6,1.0,0.6
132,132,CDH5,0.0013949267602478,TouretteSyndrome,ENSG00000179776,Tier 3B,CDH5,16,66400533.0,66438686.0,1.0,"cadherin 5, type 2 (vascular endothelium) [Source:HGNC Symbol;Acc:1764]",0.0,0.6,1.0,0.6
132,132,CDH5,0.0013949267602478,UnipolarDepression,ENSG00000179776,Tier 3B,CDH5,16,66400533.0,66438686.0,1.0,"cadherin 5, type 2 (vascular endothelium) [Source:HGNC Symbol;Acc:1764]",0.0,0.6,1.0,0.6
133,133,CD28,0.0013861668777606,MS,ENSG00000178562,Tier 1,CD28,2,204571198.0,204603635.0,1.0,CD28 molecule [Source:HGNC Symbol;Acc:1653],2.0,0.6,1.0,0.6
135,135,NLGN1,0.0013784690124864,UnipolarDepression,ENSG00000169760,Tier 3B,NLGN1,3,173114074.0,174004434.0,1.0,neuroligin 1 [Source:HGNC Symbol;Acc:14291],0.0,1.0,0.6,0.6
136,136,TGFBR2,0.0013781667555573,MigraineDisorder,ENSG00000163513,Tier 1,TGFBR2,3,30647994.0,30735634.0,1.0,"transforming growth factor, beta receptor II (70/80kDa) [Source:HGNC Symbol;Acc:11773]",1.0,1.0,1.0,0.6
136,136,TGFBR2,0.0013781667555573,Schizophrenia,ENSG00000163513,Tier 1,TGFBR2,3,30647994.0,30735634.0,1.0,"transforming growth factor, beta receptor II (70/80kDa) [Source:HGNC Symbol;Acc:11773]",1.0,1.0,1.0,0.6
138,138,DAG1,0.0013702809504555,UnipolarDepression,ENSG00000173402,Tier 3B,DAG1,3,49506146.0,49573048.0,1.0,dystroglycan 1 (dystrophin-associated glycoprotein 1) [Source:HGNC Symbol;Acc:2666],11.0,0.6,1.0,0.6
140,140,ADCY1,0.0013611151586414,BipolarDisorder,ENSG00000164742,Tier 1,ADCY1,7,45613739.0,45762715.0,1.0,adenylate cyclase 1 (brain) [Source:HGNC Symbol;Acc:232],0.0,1.0,0.6,0.6
140,140,ADCY1,0.0013611151586414,Schizophrenia,ENSG00000164742,Tier 1,ADCY1,7,45613739.0,45762715.0,1.0,adenylate cyclase 1 (brain) [Source:HGNC Symbol;Acc:232],0.0,1.0,0.6,0.6
143,143,CSF2RB,0.0013510875330428,MS,ENSG00000100368,Tier 3A,CSF2RB,22,37309670.0,37336491.0,1.0,"colony stimulating factor 2 receptor, beta, low-affinity (granulocyte-macrophage) [Source:HGNC Symbol;Acc:2436]",0.0,0.6,1.0,0.6
145,145,IL20RA,0.0013385231772622,MS,ENSG00000016402,Tier 3B,IL20RA,6,137321108.0,137366298.0,-1.0,"interleukin 20 receptor, alpha [Source:HGNC Symbol;Acc:6003]",0.0,0.6,1.0,0.6
146,146,DSCAM,0.0013283105144738,BrainAneurysm,ENSG00000171587,Tier 3A,DSCAM,21,41382926.0,42219065.0,-1.0,Down syndrome cell adhesion molecule [Source:HGNC Symbol;Acc:3039],0.0,0.6,1.0,0.6
147,147,IL2RA,0.0013250186731772,MS,ENSG00000134460,Tier 1,IL2RA,10,6052652.0,6104288.0,-1.0,"interleukin 2 receptor, alpha [Source:HGNC Symbol;Acc:6008]",16.0,0.6,1.0,0.6
151,151,BMP3,0.0012727445628751,Schizophrenia,ENSG00000152785,Tier 3A,BMP3,4,81952119.0,81978685.0,1.0,bone morphogenetic protein 3 [Source:HGNC Symbol;Acc:1070],0.0,0.6,1.0,0.6
152,152,SEMA3A,0.0012713120692266,UnipolarDepression,ENSG00000075213,Tier 3A,SEMA3A,7,83585093.0,84122040.0,-1.0,"sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3A [Source:HGNC Symbol;Acc:10723]",1.0,0.6,1.0,0.6
153,153,GRIA1,0.0012591432840274,AnorexiaNervosa,ENSG00000155511,Tier 1,GRIA1,5,152869175.0,153193429.0,1.0,"glutamate receptor, ionotropic, AMPA 1 [Source:HGNC Symbol;Acc:4571]",1.0,1.0,1.0,0.6
153,153,GRIA1,0.0012591432840274,BipolarDisorder,ENSG00000155511,Tier 1,GRIA1,5,152869175.0,153193429.0,1.0,"glutamate receptor, ionotropic, AMPA 1 [Source:HGNC Symbol;Acc:4571]",1.0,1.0,1.0,0.6
153,153,GRIA1,0.0012591432840274,OCD,ENSG00000155511,Tier 1,GRIA1,5,152869175.0,153193429.0,1.0,"glutamate receptor, ionotropic, AMPA 1 [Source:HGNC Symbol;Acc:4571]",1.0,1.0,1.0,0.6
153,153,GRIA1,0.0012591432840274,Schizophrenia,ENSG00000155511,Tier 1,GRIA1,5,152869175.0,153193429.0,1.0,"glutamate receptor, ionotropic, AMPA 1 [Source:HGNC Symbol;Acc:4571]",1.0,1.0,1.0,0.6
153,153,GRIA1,0.0012591432840274,TouretteSyndrome,ENSG00000155511,Tier 1,GRIA1,5,152869175.0,153193429.0,1.0,"glutamate receptor, ionotropic, AMPA 1 [Source:HGNC Symbol;Acc:4571]",1.0,1.0,1.0,0.6
153,153,GRIA1,0.0012591432840274,UnipolarDepression,ENSG00000155511,Tier 1,GRIA1,5,152869175.0,153193429.0,1.0,"glutamate receptor, ionotropic, AMPA 1 [Source:HGNC Symbol;Acc:4571]",1.0,1.0,1.0,0.6
155,155,PTPRD,0.0012451897853867,Schizophrenia,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05
157,157,SV2C,0.0012050186567497,PD,ENSG00000122012,Tier 2,SV2C,5,75378997.0,75649764.0,1.0,synaptic vesicle glycoprotein 2C [Source:HGNC Symbol;Acc:30670],0.0,1.0,0.6,0.6
158,158,CD47,0.0011925724637226,BipolarDisorder,ENSG00000196776,Tier 3B,CD47,3,107762145.0,107809872.0,-1.0,CD47 molecule [Source:HGNC Symbol;Acc:1682],0.0,0.6,1.0,0.6
158,158,CD47,0.0011925724637226,TouretteSyndrome,ENSG00000196776,Tier 3B,CD47,3,107762145.0,107809872.0,-1.0,CD47 molecule [Source:HGNC Symbol;Acc:1682],0.0,0.6,1.0,0.6
159,159,FLRT3,0.0011700680972665,BipolarDisorder,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05
160,160,HCRT,0.0011688211583572,NarcolepsyCataplexy,ENSG00000161610,Tier 3B,HCRT,17,40336078.0,40337470.0,-1.0,hypocretin (orexin) neuropeptide precursor [Source:HGNC Symbol;Acc:4847],0.0,0.6,1.0,0.6
160,160,HCRT,0.0011688211583572,Narcolepsy,ENSG00000161610,Tier 3B,HCRT,17,40336078.0,40337470.0,-1.0,hypocretin (orexin) neuropeptide precursor [Source:HGNC Symbol;Acc:4847],0.0,0.6,1.0,0.6
161,161,STAB1,0.0011526203091492,BipolarDisorder,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05
161,161,STAB1,0.0011526203091492,Schizophrenia,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05
162,162,NMUR2,0.0011526203091492,AnorexiaNervosa,ENSG00000132911,Tier 3B,NMUR2,5,151771093.0,151812929.0,-1.0,neuromedin U receptor 2 [Source:HGNC Symbol;Acc:16454],0.0,1.0,1.0,0.6
162,162,NMUR2,0.0011526203091492,BipolarDisorder,ENSG00000132911,Tier 3B,NMUR2,5,151771093.0,151812929.0,-1.0,neuromedin U receptor 2 [Source:HGNC Symbol;Acc:16454],0.0,1.0,1.0,0.6
162,162,NMUR2,0.0011526203091492,MigraineDisorder,ENSG00000132911,Tier 3B,NMUR2,5,151771093.0,151812929.0,-1.0,neuromedin U receptor 2 [Source:HGNC Symbol;Acc:16454],0.0,1.0,1.0,0.6
162,162,NMUR2,0.0011526203091492,OCD,ENSG00000132911,Tier 3B,NMUR2,5,151771093.0,151812929.0,-1.0,neuromedin U receptor 2 [Source:HGNC Symbol;Acc:16454],0.0,1.0,1.0,0.6
162,162,NMUR2,0.0011526203091492,Schizophrenia,ENSG00000132911,Tier 3B,NMUR2,5,151771093.0,151812929.0,-1.0,neuromedin U receptor 2 [Source:HGNC Symbol;Acc:16454],0.0,1.0,1.0,0.6
162,162,NMUR2,0.0011526203091492,TouretteSyndrome,ENSG00000132911,Tier 3B,NMUR2,5,151771093.0,151812929.0,-1.0,neuromedin U receptor 2 [Source:HGNC Symbol;Acc:16454],0.0,1.0,1.0,0.6
162,162,NMUR2,0.0011526203091492,UnipolarDepression,ENSG00000132911,Tier 3B,NMUR2,5,151771093.0,151812929.0,-1.0,neuromedin U receptor 2 [Source:HGNC Symbol;Acc:16454],0.0,1.0,1.0,0.6
163,163,NPBWR2,0.0011526203091492,RestlessLeg,ENSG00000125522,Tier 3B,NPBWR2,20,62737173.0,62738524.0,-1.0,neuropeptides B/W receptor 2 [Source:HGNC Symbol;Acc:4530],0.0,1.0,1.0,0.6
164,164,EPHA1,0.0011512514157419,AD,ENSG00000146904,Tier 1,EPHA1,7,143087382.0,143105985.0,-1.0,EPH receptor A1 [Source:HGNC Symbol;Acc:3385],1.0,1.0,0.6,0.6
166,166,CD40,0.0011382156024567,MS,ENSG00000101017,Tier 1,CD40,20,44746911.0,44758502.0,1.0,"CD40 molecule, TNF receptor superfamily member 5 [Source:HGNC Symbol;Acc:11919]",7.0,0.6,1.0,0.6
166,166,CD40,0.0011382156024567,UnipolarDepression,ENSG00000101017,Tier 1,CD40,20,44746911.0,44758502.0,1.0,"CD40 molecule, TNF receptor superfamily member 5 [Source:HGNC Symbol;Acc:11919]",7.0,0.6,1.0,0.6
171,171,UNC5A,0.0011270840189319,OCD,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05
172,172,GRN,0.0011252446503824,AD,ENSG00000030582,Tier 3A,GRN,17,42422614.0,42430470.0,1.0,granulin [Source:HGNC Symbol;Acc:4601],1.0,0.6,1.0,0.6
172,172,GRN,0.0011252446503824,FrontotemporalDementia,ENSG00000030582,Tier 3A,GRN,17,42422614.0,42430470.0,1.0,granulin [Source:HGNC Symbol;Acc:4601],1.0,0.6,1.0,0.6
174,174,BTN1A1,0.0011193697623225,BipolarDisorder,ENSG00000124557,Tier 3A,BTN1A1,6,26501449.0,26510650.0,1.0,"butyrophilin, subfamily 1, member A1 [Source:HGNC Symbol;Acc:1135]",1.0,0.6,1.0,0.6
174,174,BTN1A1,0.0011193697623225,UnipolarDepression,ENSG00000124557,Tier 3A,BTN1A1,6,26501449.0,26510650.0,1.0,"butyrophilin, subfamily 1, member A1 [Source:HGNC Symbol;Acc:1135]",1.0,0.6,1.0,0.6
175,175,CD69,0.0011140670228194,MS,ENSG00000110848,Tier 3A,CD69,12,9905082.0,9913497.0,-1.0,CD69 molecule [Source:HGNC Symbol;Acc:1694],1.0,0.6,1.0,0.6
176,176,KL,0.0011087546854933,BrainAneurysm,ENSG00000133116,Tier 3B,KL,13,33590207.0,33640282.0,1.0,klotho [Source:HGNC Symbol;Acc:6344],0.0,0.6,1.0,0.6
177,177,EDNRA,0.0011060376493475,BrainAneurysm,ENSG00000151617,Tier 1,EDNRA,4,148402069.0,148466106.0,1.0,endothelin receptor type A [Source:HGNC Symbol;Acc:3179],2.0,1.0,1.0,0.6
179,179,ROBO2,0.0011012254178074,Schizophrenia,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05
179,179,ROBO2,0.0011012254178074,UnipolarDepression,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05
180,180,PTPRG,0.0011003735605118,AD,ENSG00000144724,Tier 3A,PTPRG,3,61547243.0,62283288.0,1.0,"protein tyrosine phosphatase, receptor type, G [Source:HGNC Symbol;Acc:9671]",0.0,1.0,1.0,0.6
182,182,TACR3,0.0010685648108598,UnipolarDepression,ENSG00000169836,Tier 1,TACR3,4,104507188.0,104640973.0,-1.0,tachykinin receptor 3 [Source:HGNC Symbol;Acc:11528],1.0,1.0,1.0,0.6
183,183,IL21,0.0010676016973118,BipolarDisorder,ENSG00000138684,Tier 3A,IL21,4,123533783.0,123542224.0,-1.0,interleukin 21 [Source:HGNC Symbol;Acc:6005],9.0,0.6,1.0,0.6
191,191,PTPRK,0.0010349675292469,MS,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05
193,193,NOS1,0.0010341726137663,NeuroticDisorder,ENSG00000089250,Tier 1,NOS1,12,117645947.0,117889975.0,-1.0,nitric oxide synthase 1 (neuronal) [Source:HGNC Symbol;Acc:7872],0.0,1.0,0.6,1.0
193,193,NOS1,0.0010341726137663,Schizophrenia,ENSG00000089250,Tier 1,NOS1,12,117645947.0,117889975.0,-1.0,nitric oxide synthase 1 (neuronal) [Source:HGNC Symbol;Acc:7872],0.0,1.0,0.6,1.0
193,193,NOS1,0.0010341726137663,UnipolarDepression,ENSG00000089250,Tier 1,NOS1,12,117645947.0,117889975.0,-1.0,nitric oxide synthase 1 (neuronal) [Source:HGNC Symbol;Acc:7872],0.0,1.0,0.6,1.0
195,195,TGFBR3,0.001023649092478,MS,ENSG00000069702,Tier 3A,TGFBR3,1,92145902.0,92371892.0,-1.0,"transforming growth factor, beta receptor III [Source:HGNC Symbol;Acc:11774]",0.0,0.6,1.0,0.6
196,196,OPRD1,0.0010222480427335,Schizophrenia,ENSG00000116329,Tier 1,OPRD1,1,29138654.0,29190208.0,1.0,"opioid receptor, delta 1 [Source:HGNC Symbol;Acc:8153]",0.0,1.0,0.6,0.6
197,197,IL7,0.001021700345373,MS,ENSG00000104432,Tier 3A,IL7,8,79587978.0,79717758.0,-1.0,interleukin 7 [Source:HGNC Symbol;Acc:6023],0.0,0.6,1.0,0.6
202,202,EPHA5,0.0010070239918862,Schizophrenia,ENSG00000145242,Tier 1,EPHA5,4,66185281.0,66536213.0,-1.0,EPH receptor A5 [Source:HGNC Symbol;Acc:3389],0.0,1.0,1.0,0.6
203,203,MPL,0.0009983400659855,AnorexiaNervosa,ENSG00000117400,Tier 1,MPL,1,43803478.0,43818443.0,1.0,myeloproliferative leukemia virus oncogene [Source:HGNC Symbol;Acc:7217],0.0,1.0,1.0,0.6
203,203,MPL,0.0009983400659855,BipolarDisorder,ENSG00000117400,Tier 1,MPL,1,43803478.0,43818443.0,1.0,myeloproliferative leukemia virus oncogene [Source:HGNC Symbol;Acc:7217],0.0,1.0,1.0,0.6
203,203,MPL,0.0009983400659855,OCD,ENSG00000117400,Tier 1,MPL,1,43803478.0,43818443.0,1.0,myeloproliferative leukemia virus oncogene [Source:HGNC Symbol;Acc:7217],0.0,1.0,1.0,0.6
203,203,MPL,0.0009983400659855,Schizophrenia,ENSG00000117400,Tier 1,MPL,1,43803478.0,43818443.0,1.0,myeloproliferative leukemia virus oncogene [Source:HGNC Symbol;Acc:7217],0.0,1.0,1.0,0.6
203,203,MPL,0.0009983400659855,TouretteSyndrome,ENSG00000117400,Tier 1,MPL,1,43803478.0,43818443.0,1.0,myeloproliferative leukemia virus oncogene [Source:HGNC Symbol;Acc:7217],0.0,1.0,1.0,0.6
203,203,MPL,0.0009983400659855,UnipolarDepression,ENSG00000117400,Tier 1,MPL,1,43803478.0,43818443.0,1.0,myeloproliferative leukemia virus oncogene [Source:HGNC Symbol;Acc:7217],0.0,1.0,1.0,0.6
204,204,LGI1,0.0009978757023433,PartialEpilepsy,ENSG00000108231,Tier 3B,LGI1,10,95517566.0,95557916.0,1.0,"leucine-rich, glioma inactivated 1 [Source:HGNC Symbol;Acc:6572]",0.0,0.6,1.0,0.6
207,207,SEMA6D,0.0009863047949242,AnorexiaNervosa,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05
207,207,SEMA6D,0.0009863047949242,MajorDepressiveDisorder,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05
207,207,SEMA6D,0.0009863047949242,RestlessLeg,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05
207,207,SEMA6D,0.0009863047949242,Schizophrenia,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05
207,207,SEMA6D,0.0009863047949242,UnipolarDepression,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05
211,211,PVR,0.0009701672997397,MS,ENSG00000073008,Tier 3A,PVR,19,45147098.0,45166850.0,1.0,poliovirus receptor [Source:HGNC Symbol;Acc:9705],0.0,0.6,1.0,0.6
212,212,CDH11,0.0009602860938538,Schizophrenia,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05
213,213,MAP4K4,0.0009589335770544,PD,ENSG00000071054,Tier 1,MAP4K4,2,102313312.0,102511149.0,1.0,mitogen-activated protein kinase kinase kinase kinase 4 [Source:HGNC Symbol;Acc:6866],0.0,1.0,0.6,0.6
214,214,S1PR1,0.0009543232504382,PD,ENSG00000170989,Tier 1,S1PR1,1,101702444.0,101707074.0,1.0,sphingosine-1-phosphate receptor 1 [Source:HGNC Symbol;Acc:3165],0.0,1.0,1.0,0.6
215,215,ECM1,0.0009486939729334,MigraineDisorder,ENSG00000143369,Tier 3B,ECM1,1,150480538.0,150486265.0,1.0,extracellular matrix protein 1 [Source:HGNC Symbol;Acc:3153],1.0,0.6,1.0,0.6
221,221,NCR2,0.0009363323584603,AD,ENSG00000096264,Tier 3A,NCR2,6,41303393.0,41318625.0,1.0,natural cytotoxicity triggering receptor 2 [Source:HGNC Symbol;Acc:6732],0.0,0.6,1.0,0.6
222,222,MPO,0.0009327328537873,AD,ENSG00000005381,Tier 1,MPO,17,56347217.0,56358296.0,-1.0,myeloperoxidase [Source:HGNC Symbol;Acc:7218],1.0,1.0,1.0,1.0
224,224,JAG1,0.000931278229519,MigraineDisorder,ENSG00000101384,Tier 3A,JAG1,20,10618332.0,10654694.0,-1.0,jagged 1 [Source:HGNC Symbol;Acc:6188],1.0,0.6,1.0,0.6
230,230,SLIT3,0.0008974577663855,BipolarDisorder,ENSG00000184347,Tier 3A,SLIT3,5,168088745.0,168728133.0,-1.0,slit homolog 3 (Drosophila) [Source:HGNC Symbol;Acc:11087],3.0,0.6,1.0,0.6
231,231,SYNJ1,0.0008951372512445,PD,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05
232,232,CD5,0.0008948475553844,MS,ENSG00000110448,Tier 1,CD5,11,60869867.0,60895324.0,1.0,CD5 molecule [Source:HGNC Symbol;Acc:1685],0.0,0.6,1.0,0.6
233,233,LRIG1,0.0008903408945545,AD,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05
238,238,CNTN4,0.0008807996889807,AnorexiaNervosa,ENSG00000144619,Tier 3A,CNTN4,3,2140497.0,3099645.0,1.0,contactin 4 [Source:HGNC Symbol;Acc:2174],2.0,0.6,1.0,0.6
238,238,CNTN4,0.0008807996889807,BipolarDisorder,ENSG00000144619,Tier 3A,CNTN4,3,2140497.0,3099645.0,1.0,contactin 4 [Source:HGNC Symbol;Acc:2174],2.0,0.6,1.0,0.6
238,238,CNTN4,0.0008807996889807,OCD,ENSG00000144619,Tier 3A,CNTN4,3,2140497.0,3099645.0,1.0,contactin 4 [Source:HGNC Symbol;Acc:2174],2.0,0.6,1.0,0.6
238,238,CNTN4,0.0008807996889807,Schizophrenia,ENSG00000144619,Tier 3A,CNTN4,3,2140497.0,3099645.0,1.0,contactin 4 [Source:HGNC Symbol;Acc:2174],2.0,0.6,1.0,0.6
238,238,CNTN4,0.0008807996889807,TouretteSyndrome,ENSG00000144619,Tier 3A,CNTN4,3,2140497.0,3099645.0,1.0,contactin 4 [Source:HGNC Symbol;Acc:2174],2.0,0.6,1.0,0.6
238,238,CNTN4,0.0008807996889807,UnipolarDepression,ENSG00000144619,Tier 3A,CNTN4,3,2140497.0,3099645.0,1.0,contactin 4 [Source:HGNC Symbol;Acc:2174],2.0,0.6,1.0,0.6
240,240,MERTK,0.0008751813041631,MS,ENSG00000153208,Tier 1,MERTK,2,112656056.0,112787138.0,1.0,c-mer proto-oncogene tyrosine kinase [Source:HGNC Symbol;Acc:7027],2.0,1.0,1.0,0.6
242,242,RPSA,0.0008726419960509,Schizophrenia,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05
246,246,TNFRSF25,0.000851786294761,MS,ENSG00000215788,Tier 3A,TNFRSF25,1,6521211.0,6526255.0,-1.0,"tumor necrosis factor receptor superfamily, member 25 [Source:HGNC Symbol;Acc:11910]",0.0,0.6,1.0,0.6
247,247,CD33,0.0008514855281286,AD,ENSG00000105383,Tier 1,CD33,19,51728320.0,51747115.0,1.0,CD33 molecule [Source:HGNC Symbol;Acc:1659],1.0,0.6,1.0,0.6
248,248,PLXNA4,0.0008502891287072,BipolarDisorder,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05
248,248,PLXNA4,0.0008502891287072,Schizophrenia,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05
249,249,SEMA3E,0.0008366110857484,UnipolarDepression,ENSG00000170381,Tier 3B,SEMA3E,7,82993222.0,83278326.0,-1.0,"sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3E [Source:HGNC Symbol;Acc:10727]",0.0,0.6,1.0,0.6
252,252,CHRNA1,0.0008209894436105,PartialEpilepsy,ENSG00000138435,Tier 1,CHRNA1,2,175612320.0,175629200.0,-1.0,"cholinergic receptor, nicotinic, alpha 1 (muscle) [Source:HGNC Symbol;Acc:1955]",0.0,1.0,1.0,0.6
254,254,CLEC2D,0.000817071877835,MS,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05
258,258,CD46,0.0008072329343492,Schizophrenia,ENSG00000117335,Tier 3A,CD46,1,207925402.0,207968858.0,1.0,"CD46 molecule, complement regulatory protein [Source:HGNC Symbol;Acc:6953]",6.0,0.6,1.0,0.6
259,259,PTK7,0.0008041139961351,Schizophrenia,ENSG00000112655,Tier 3B,PTK7,6,43044006.0,43129457.0,1.0,protein tyrosine kinase 7 [Source:HGNC Symbol;Acc:9618],0.0,1.0,1.0,0.6
261,261,ROBO1,0.0008012815468878,UnipolarDepression,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05
264,264,HAVCR1,0.0007923930269413,AD,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05
265,265,LRRC4C,0.0007923930269413,MS,ENSG00000148948,Tier 3B,LRRC4C,11,40135753.0,41481323.0,-1.0,leucine rich repeat containing 4C [Source:HGNC Symbol;Acc:29317],0.0,1.0,0.6,0.6
266,266,GPR35,0.0007923930269413,BipolarDisorder,ENSG00000178623,Tier 1,GPR35,2,241544848.0,241570676.0,1.0,G protein-coupled receptor 35 [Source:HGNC Symbol;Acc:4492],2.0,1.0,1.0,0.6
267,267,MAPT,0.0007923930269413,AD,ENSG00000186868,Tier 1,MAPT,17,43971748.0,44105700.0,1.0,microtubule-associated protein tau [Source:HGNC Symbol;Acc:6893],19.0,1.0,0.6,0.6
267,267,MAPT,0.0007923930269413,FrontotemporalDementia,ENSG00000186868,Tier 1,MAPT,17,43971748.0,44105700.0,1.0,microtubule-associated protein tau [Source:HGNC Symbol;Acc:6893],19.0,1.0,0.6,0.6
267,267,MAPT,0.0007923930269413,NeuroticDisorder,ENSG00000186868,Tier 1,MAPT,17,43971748.0,44105700.0,1.0,microtubule-associated protein tau [Source:HGNC Symbol;Acc:6893],19.0,1.0,0.6,0.6
267,267,MAPT,0.0007923930269413,PD,ENSG00000186868,Tier 1,MAPT,17,43971748.0,44105700.0,1.0,microtubule-associated protein tau [Source:HGNC Symbol;Acc:6893],19.0,1.0,0.6,0.6
267,267,MAPT,0.0007923930269413,ProgressiveSupranuclearPalsy,ENSG00000186868,Tier 1,MAPT,17,43971748.0,44105700.0,1.0,microtubule-associated protein tau [Source:HGNC Symbol;Acc:6893],19.0,1.0,0.6,0.6
269,269,SORL1,0.0007923930269413,AD,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05
273,273,HTR6,0.0007923930269413,BipolarDisorder,ENSG00000158748,Tier 1,HTR6,1,19991780.0,20006055.0,1.0,"5-hydroxytryptamine (serotonin) receptor 6, G protein-coupled [Source:HGNC Symbol;Acc:5301]",0.0,1.0,1.0,0.6
275,275,STX4,0.0007923930269413,AD,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05
275,275,STX4,0.0007923930269413,PD,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05
276,276,BTN2A2,0.0007923930269413,MajorDepressiveDisorder,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05
276,276,BTN2A2,0.0007923930269413,Schizophrenia,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05
279,279,LINGO1,0.0007923930269413,EssentialTremor,ENSG00000169783,Tier 1,LINGO1,15,77905369.0,78113242.0,-1.0,leucine rich repeat and Ig domain containing 1 [Source:HGNC Symbol;Acc:21205],1.0,0.6,1.0,0.6
279,279,LINGO1,0.0007923930269413,NeuroticDisorder,ENSG00000169783,Tier 1,LINGO1,15,77905369.0,78113242.0,-1.0,leucine rich repeat and Ig domain containing 1 [Source:HGNC Symbol;Acc:21205],1.0,0.6,1.0,0.6
279,279,LINGO1,0.0007923930269413,Schizophrenia,ENSG00000169783,Tier 1,LINGO1,15,77905369.0,78113242.0,-1.0,leucine rich repeat and Ig domain containing 1 [Source:HGNC Symbol;Acc:21205],1.0,0.6,1.0,0.6
279,279,LINGO1,0.0007923930269413,UnipolarDepression,ENSG00000169783,Tier 1,LINGO1,15,77905369.0,78113242.0,-1.0,leucine rich repeat and Ig domain containing 1 [Source:HGNC Symbol;Acc:21205],1.0,0.6,1.0,0.6
280,280,TYMP,0.0007923930269413,MS,ENSG00000025708,Tier 2,TYMP,22,50964181.0,50968485.0,-1.0,thymidine phosphorylase [Source:HGNC Symbol;Acc:3148],5.0,1.0,0.6,0.6
286,286,SLC6A4,0.0007923930269413,OCD,ENSG00000108576,Tier 1,SLC6A4,17,28521337.0,28563020.0,-1.0,"solute carrier family 6 (neurotransmitter transporter), member 4 [Source:HGNC Symbol;Acc:11050]",1.0,1.0,0.6,0.6
287,287,IZUMO1,0.0007923930269413,Schizophrenia,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05
295,295,CHRNA7,0.0007868127231405,PartialEpilepsy,ENSG00000175344,Tier 1,CHRNA7,15,32322691.0,32464722.0,1.0,"cholinergic receptor, nicotinic, alpha 7 (neuronal) [Source:HGNC Symbol;Acc:1960]",0.0,1.0,1.0,0.6
296,296,ADGRV1,0.0007849639093336,EssentialTremor,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05
296,296,ADGRV1,0.0007849639093336,Schizophrenia,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05
298,298,NID1,0.0007805783199644,PartialEpilepsy,ENSG00000116962,Tier 3A,NID1,1,236139130.0,236228462.0,-1.0,nidogen 1 [Source:HGNC Symbol;Acc:7821],0.0,0.6,1.0,0.6
299,299,MAP2K2,0.0007768489966831,MigraineDisorder,ENSG00000126934,Tier 1,MAP2K2,19,4090319.0,4124126.0,-1.0,mitogen-activated protein kinase kinase 2 [Source:HGNC Symbol;Acc:6842],0.0,1.0,0.6,0.6
306,306,KMT2E,0.0007599824608988,AnorexiaNervosa,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05
306,306,KMT2E,0.0007599824608988,Schizophrenia,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05
308,308,GRIN2A,0.0007587193438185,AnorexiaNervosa,ENSG00000183454,Tier 1,GRIN2A,16,9852376.0,10276611.0,-1.0,"glutamate receptor, ionotropic, N-methyl D-aspartate 2A [Source:HGNC Symbol;Acc:4585]",3.0,1.0,0.6,0.6
308,308,GRIN2A,0.0007587193438185,BipolarDisorder,ENSG00000183454,Tier 1,GRIN2A,16,9852376.0,10276611.0,-1.0,"glutamate receptor, ionotropic, N-methyl D-aspartate 2A [Source:HGNC Symbol;Acc:4585]",3.0,1.0,0.6,0.6
308,308,GRIN2A,0.0007587193438185,OCD,ENSG00000183454,Tier 1,GRIN2A,16,9852376.0,10276611.0,-1.0,"glutamate receptor, ionotropic, N-methyl D-aspartate 2A [Source:HGNC Symbol;Acc:4585]",3.0,1.0,0.6,0.6
308,308,GRIN2A,0.0007587193438185,PartialEpilepsy,ENSG00000183454,Tier 1,GRIN2A,16,9852376.0,10276611.0,-1.0,"glutamate receptor, ionotropic, N-methyl D-aspartate 2A [Source:HGNC Symbol;Acc:4585]",3.0,1.0,0.6,0.6
308,308,GRIN2A,0.0007587193438185,Schizophrenia,ENSG00000183454,Tier 1,GRIN2A,16,9852376.0,10276611.0,-1.0,"glutamate receptor, ionotropic, N-methyl D-aspartate 2A [Source:HGNC Symbol;Acc:4585]",3.0,1.0,0.6,0.6
308,308,GRIN2A,0.0007587193438185,TouretteSyndrome,ENSG00000183454,Tier 1,GRIN2A,16,9852376.0,10276611.0,-1.0,"glutamate receptor, ionotropic, N-methyl D-aspartate 2A [Source:HGNC Symbol;Acc:4585]",3.0,1.0,0.6,0.6
308,308,GRIN2A,0.0007587193438185,UnipolarDepression,ENSG00000183454,Tier 1,GRIN2A,16,9852376.0,10276611.0,-1.0,"glutamate receptor, ionotropic, N-methyl D-aspartate 2A [Source:HGNC Symbol;Acc:4585]",3.0,1.0,0.6,0.6
325,325,TREM2,0.0007522418552259,FrontotemporalDementia,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05
326,326,CRHR1,0.0007518826333806,PD,ENSG00000120088,Tier 1,CRHR1,17,43699267.0,43913194.0,1.0,corticotropin releasing hormone receptor 1 [Source:HGNC Symbol;Acc:2357],18.0,1.0,1.0,0.6
326,326,CRHR1,0.0007518826333806,Schizophrenia,ENSG00000120088,Tier 1,CRHR1,17,43699267.0,43913194.0,1.0,corticotropin releasing hormone receptor 1 [Source:HGNC Symbol;Acc:2357],18.0,1.0,1.0,0.6
326,326,CRHR1,0.0007518826333806,UnipolarDepression,ENSG00000120088,Tier 1,CRHR1,17,43699267.0,43913194.0,1.0,corticotropin releasing hormone receptor 1 [Source:HGNC Symbol;Acc:2357],18.0,1.0,1.0,0.6
327,327,ABCB1,0.0007513104722657,Schizophrenia,ENSG00000085563,Tier 1,ABCB1,7,87133175.0,87342611.0,-1.0,"ATP-binding cassette, sub-family B (MDR/TAP), member 1 [Source:HGNC Symbol;Acc:40]",0.0,1.0,1.0,1.0
328,328,LTBR,0.0007497094846753,MS,ENSG00000111321,Tier 1,LTBR,12,6484211.0,6500733.0,1.0,"lymphotoxin beta receptor (TNFR superfamily, member 3) [Source:HGNC Symbol;Acc:6718]",1.0,0.6,1.0,0.6
330,330,PTPRF,0.0007477680653355,AnorexiaNervosa,ENSG00000142949,Tier 2,PTPRF,1,43990858.0,44089343.0,1.0,"protein tyrosine phosphatase, receptor type, F [Source:HGNC Symbol;Acc:9670]",2.0,1.0,0.6,0.6
330,330,PTPRF,0.0007477680653355,BipolarDisorder,ENSG00000142949,Tier 2,PTPRF,1,43990858.0,44089343.0,1.0,"protein tyrosine phosphatase, receptor type, F [Source:HGNC Symbol;Acc:9670]",2.0,1.0,0.6,0.6
330,330,PTPRF,0.0007477680653355,OCD,ENSG00000142949,Tier 2,PTPRF,1,43990858.0,44089343.0,1.0,"protein tyrosine phosphatase, receptor type, F [Source:HGNC Symbol;Acc:9670]",2.0,1.0,0.6,0.6
330,330,PTPRF,0.0007477680653355,Schizophrenia,ENSG00000142949,Tier 2,PTPRF,1,43990858.0,44089343.0,1.0,"protein tyrosine phosphatase, receptor type, F [Source:HGNC Symbol;Acc:9670]",2.0,1.0,0.6,0.6
330,330,PTPRF,0.0007477680653355,TouretteSyndrome,ENSG00000142949,Tier 2,PTPRF,1,43990858.0,44089343.0,1.0,"protein tyrosine phosphatase, receptor type, F [Source:HGNC Symbol;Acc:9670]",2.0,1.0,0.6,0.6
330,330,PTPRF,0.0007477680653355,UnipolarDepression,ENSG00000142949,Tier 2,PTPRF,1,43990858.0,44089343.0,1.0,"protein tyrosine phosphatase, receptor type, F [Source:HGNC Symbol;Acc:9670]",2.0,1.0,0.6,0.6
338,338,ATM,0.0007398831811983,PD,ENSG00000149311,Tier 2,ATM,11,108093211.0,108239829.0,1.0,ataxia telangiectasia mutated [Source:HGNC Symbol;Acc:795],3.0,1.0,0.6,0.6
339,339,SEMA3C,0.0007393853346553,AD,ENSG00000075223,Tier 3A,SEMA3C,7,80371854.0,80551675.0,-1.0,"sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3C [Source:HGNC Symbol;Acc:10725]",1.0,0.6,1.0,0.6
342,342,IDE,0.0007350466270099,ALS,ENSG00000119912,Tier 2,IDE,10,94211441.0,94333833.0,-1.0,insulin-degrading enzyme [Source:HGNC Symbol;Acc:5381],10.0,1.0,1.0,0.6
346,346,SEMA3B,0.0007271482863907,NeuroticDisorder,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05
351,351,SHANK2,0.0007198632165877,BipolarDisorder,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05
351,351,SHANK2,0.0007198632165877,UnipolarDepression,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05
357,357,MC4R,0.0007036090019251,Schizophrenia,ENSG00000166603,Tier 1,MC4R,18,58038564.0,58040001.0,-1.0,melanocortin 4 receptor [Source:HGNC Symbol;Acc:6932],0.0,1.0,1.0,0.6
364,364,PLCB1,0.0006985527736559,PartialEpilepsy,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05
367,367,CSF1R,0.000695767831323,AD,ENSG00000182578,Tier 1,CSF1R,5,149432854.0,149492935.0,-1.0,colony stimulating factor 1 receptor [Source:HGNC Symbol;Acc:2433],0.0,1.0,1.0,0.6
367,367,CSF1R,0.000695767831323,FrontotemporalDementia,ENSG00000182578,Tier 1,CSF1R,5,149432854.0,149492935.0,-1.0,colony stimulating factor 1 receptor [Source:HGNC Symbol;Acc:2433],0.0,1.0,1.0,0.6
367,367,CSF1R,0.000695767831323,PD,ENSG00000182578,Tier 1,CSF1R,5,149432854.0,149492935.0,-1.0,colony stimulating factor 1 receptor [Source:HGNC Symbol;Acc:2433],0.0,1.0,1.0,0.6
375,375,CD38,0.0006908638941333,PD,ENSG00000004468,Tier 1,CD38,4,15779898.0,15854853.0,1.0,CD38 molecule [Source:HGNC Symbol;Acc:1667],0.0,0.6,1.0,0.6
377,377,SCN9A,0.0006898644814289,PartialEpilepsy,ENSG00000169432,Tier 1,SCN9A,2,167051695.0,167232503.0,-1.0,"sodium channel, voltage-gated, type IX, alpha subunit [Source:HGNC Symbol;Acc:10597]",0.0,1.0,0.6,0.6
380,380,MMP3,0.0006846563469666,AD,ENSG00000149968,Tier 1,MMP3,11,102706532.0,102714534.0,-1.0,"matrix metallopeptidase 3 (stromelysin 1, progelatinase) [Source:HGNC Symbol;Acc:7173]",7.0,1.0,1.0,0.6
381,381,EDAR,0.0006826035729257,AD,ENSG00000135960,Tier 3A,EDAR,2,109510927.0,109605828.0,-1.0,ectodysplasin A receptor [Source:HGNC Symbol;Acc:2895],0.0,0.6,1.0,0.6
396,396,ILDR1,0.0006671133863501,MS,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05
398,398,MST1R,0.0006644857304993,Schizophrenia,ENSG00000164078,Tier 1,MST1R,3,49924435.0,49941299.0,-1.0,macrophage stimulating 1 receptor (c-met-related tyrosine kinase) [Source:HGNC Symbol;Acc:7381],3.0,1.0,1.0,0.6
400,400,CD86,0.0006622378631895,MS,ENSG00000114013,Tier 1,CD86,3,121774213.0,121839983.0,1.0,CD86 molecule [Source:HGNC Symbol;Acc:1705],1.0,0.6,1.0,0.6
402,402,CD226,0.000661069066107,MS,ENSG00000150637,Tier 3A,CD226,18,67498394.0,67629039.0,-1.0,CD226 molecule [Source:HGNC Symbol;Acc:16961],7.0,0.6,1.0,0.6
405,405,MAP2K5,0.0006544837006514,BipolarDisorder,ENSG00000137764,Tier 1,MAP2K5,15,67835047.0,68099461.0,1.0,mitogen-activated protein kinase kinase 5 [Source:HGNC Symbol;Acc:6845],7.0,1.0,0.6,0.6
405,405,MAP2K5,0.0006544837006514,RestlessLeg,ENSG00000137764,Tier 1,MAP2K5,15,67835047.0,68099461.0,1.0,mitogen-activated protein kinase kinase 5 [Source:HGNC Symbol;Acc:6845],7.0,1.0,0.6,0.6
408,408,PLCG2,0.0006491324190309,AD,ENSG00000197943,Tier 2,PLCG2,16,81772702.0,81991899.0,1.0,"phospholipase C, gamma 2 (phosphatidylinositol-specific) [Source:HGNC Symbol;Acc:9066]",0.0,1.0,0.6,0.6
410,410,FES,0.000646687057339,AnorexiaNervosa,ENSG00000182511,Tier 2,FES,15,91426925.0,91439006.0,1.0,feline sarcoma oncogene [Source:HGNC Symbol;Acc:3657],4.0,1.0,0.6,0.6
410,410,FES,0.000646687057339,BipolarDisorder,ENSG00000182511,Tier 2,FES,15,91426925.0,91439006.0,1.0,feline sarcoma oncogene [Source:HGNC Symbol;Acc:3657],4.0,1.0,0.6,0.6
410,410,FES,0.000646687057339,MajorDepressiveDisorder,ENSG00000182511,Tier 2,FES,15,91426925.0,91439006.0,1.0,feline sarcoma oncogene [Source:HGNC Symbol;Acc:3657],4.0,1.0,0.6,0.6
410,410,FES,0.000646687057339,OCD,ENSG00000182511,Tier 2,FES,15,91426925.0,91439006.0,1.0,feline sarcoma oncogene [Source:HGNC Symbol;Acc:3657],4.0,1.0,0.6,0.6
410,410,FES,0.000646687057339,Schizophrenia,ENSG00000182511,Tier 2,FES,15,91426925.0,91439006.0,1.0,feline sarcoma oncogene [Source:HGNC Symbol;Acc:3657],4.0,1.0,0.6,0.6
410,410,FES,0.000646687057339,TouretteSyndrome,ENSG00000182511,Tier 2,FES,15,91426925.0,91439006.0,1.0,feline sarcoma oncogene [Source:HGNC Symbol;Acc:3657],4.0,1.0,0.6,0.6
410,410,FES,0.000646687057339,UnipolarDepression,ENSG00000182511,Tier 2,FES,15,91426925.0,91439006.0,1.0,feline sarcoma oncogene [Source:HGNC Symbol;Acc:3657],4.0,1.0,0.6,0.6
417,417,INPP5D,0.0006416209443745,AD,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05
428,428,DCLK3,0.0006382795879061,AnorexiaNervosa,ENSG00000163673,Tier 1,DCLK3,3,36753913.0,36781352.0,-1.0,doublecortin-like kinase 3 [Source:HGNC Symbol;Acc:19005],0.0,1.0,0.6,0.6
428,428,DCLK3,0.0006382795879061,BipolarDisorder,ENSG00000163673,Tier 1,DCLK3,3,36753913.0,36781352.0,-1.0,doublecortin-like kinase 3 [Source:HGNC Symbol;Acc:19005],0.0,1.0,0.6,0.6
428,428,DCLK3,0.0006382795879061,OCD,ENSG00000163673,Tier 1,DCLK3,3,36753913.0,36781352.0,-1.0,doublecortin-like kinase 3 [Source:HGNC Symbol;Acc:19005],0.0,1.0,0.6,0.6
428,428,DCLK3,0.0006382795879061,Schizophrenia,ENSG00000163673,Tier 1,DCLK3,3,36753913.0,36781352.0,-1.0,doublecortin-like kinase 3 [Source:HGNC Symbol;Acc:19005],0.0,1.0,0.6,0.6
428,428,DCLK3,0.0006382795879061,TouretteSyndrome,ENSG00000163673,Tier 1,DCLK3,3,36753913.0,36781352.0,-1.0,doublecortin-like kinase 3 [Source:HGNC Symbol;Acc:19005],0.0,1.0,0.6,0.6
428,428,DCLK3,0.0006382795879061,UnipolarDepression,ENSG00000163673,Tier 1,DCLK3,3,36753913.0,36781352.0,-1.0,doublecortin-like kinase 3 [Source:HGNC Symbol;Acc:19005],0.0,1.0,0.6,0.6
437,437,FCGR2A,0.0006278529992704,PD,ENSG00000143226,Tier 3A,FCGR2A,1,161475220.0,161493803.0,1.0,"Fc fragment of IgG, low affinity IIa, receptor (CD32) [Source:HGNC Symbol;Acc:3616]",6.0,0.6,1.0,0.6
438,438,PLA2G6,0.0006276772716588,PD,ENSG00000184381,Tier 2,PLA2G6,22,38507502.0,38601697.0,-1.0,"phospholipase A2, group VI (cytosolic, calcium-independent) [Source:HGNC Symbol;Acc:9039]",4.0,1.0,0.6,0.6
449,449,CCRL2,0.0006169279846759,AD,ENSG00000121797,Tier 3B,CCRL2,3,46448654.0,46454488.0,1.0,chemokine (C-C motif) receptor-like 2 [Source:HGNC Symbol;Acc:1612],2.0,1.0,1.0,0.6
464,464,NEGR1,0.0006107346504871,AnorexiaNervosa,ENSG00000172260,Tier 3A,NEGR1,1,71861623.0,72748417.0,-1.0,neuronal growth regulator 1 [Source:HGNC Symbol;Acc:17302],10.0,0.6,1.0,0.6
464,464,NEGR1,0.0006107346504871,BipolarDisorder,ENSG00000172260,Tier 3A,NEGR1,1,71861623.0,72748417.0,-1.0,neuronal growth regulator 1 [Source:HGNC Symbol;Acc:17302],10.0,0.6,1.0,0.6
464,464,NEGR1,0.0006107346504871,MajorDepressiveDisorder,ENSG00000172260,Tier 3A,NEGR1,1,71861623.0,72748417.0,-1.0,neuronal growth regulator 1 [Source:HGNC Symbol;Acc:17302],10.0,0.6,1.0,0.6
464,464,NEGR1,0.0006107346504871,OCD,ENSG00000172260,Tier 3A,NEGR1,1,71861623.0,72748417.0,-1.0,neuronal growth regulator 1 [Source:HGNC Symbol;Acc:17302],10.0,0.6,1.0,0.6
464,464,NEGR1,0.0006107346504871,Schizophrenia,ENSG00000172260,Tier 3A,NEGR1,1,71861623.0,72748417.0,-1.0,neuronal growth regulator 1 [Source:HGNC Symbol;Acc:17302],10.0,0.6,1.0,0.6
464,464,NEGR1,0.0006107346504871,TouretteSyndrome,ENSG00000172260,Tier 3A,NEGR1,1,71861623.0,72748417.0,-1.0,neuronal growth regulator 1 [Source:HGNC Symbol;Acc:17302],10.0,0.6,1.0,0.6
464,464,NEGR1,0.0006107346504871,UnipolarDepression,ENSG00000172260,Tier 3A,NEGR1,1,71861623.0,72748417.0,-1.0,neuronal growth regulator 1 [Source:HGNC Symbol;Acc:17302],10.0,0.6,1.0,0.6
468,468,PLXNC1,0.0006069675592004,MS,ENSG00000136040,Tier 3B,PLXNC1,12,94542499.0,94701451.0,1.0,plexin C1 [Source:HGNC Symbol;Acc:9106],0.0,0.6,1.0,0.6
471,471,MICB,0.0006036003133273,UnipolarDepression,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05
472,472,MICA,0.0006036003133273,BipolarDisorder,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05
473,473,PTPRJ,0.0006027310466741,AD,ENSG00000149177,Tier 3A,PTPRJ,11,48002113.0,48189670.0,1.0,"protein tyrosine phosphatase, receptor type, J [Source:HGNC Symbol;Acc:9673]",7.0,0.6,1.0,0.6
479,479,LRFN5,0.0005984821310111,AnorexiaNervosa,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05
479,479,LRFN5,0.0005984821310111,BipolarDisorder,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05
479,479,LRFN5,0.0005984821310111,MajorDepressiveDisorder,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05
479,479,LRFN5,0.0005984821310111,OCD,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05
479,479,LRFN5,0.0005984821310111,Schizophrenia,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05
479,479,LRFN5,0.0005984821310111,TouretteSyndrome,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05
479,479,LRFN5,0.0005984821310111,UnipolarDepression,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05
481,481,CD58,0.0005973349474925,MS,ENSG00000116815,Tier 3A,CD58,1,117057157.0,117113661.0,-1.0,CD58 molecule [Source:HGNC Symbol;Acc:1688],3.0,0.6,1.0,0.6
483,483,SLITRK1,0.0005918667211203,TouretteSyndrome,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05
489,489,CHRNA4,0.0005839892024484,ALS,ENSG00000101204,Tier 1,CHRNA4,20,61975420.0,62009753.0,-1.0,"cholinergic receptor, nicotinic, alpha 4 (neuronal) [Source:HGNC Symbol;Acc:1958]",0.0,1.0,0.6,0.6
489,489,CHRNA4,0.0005839892024484,FrontotemporalDementia,ENSG00000101204,Tier 1,CHRNA4,20,61975420.0,62009753.0,-1.0,"cholinergic receptor, nicotinic, alpha 4 (neuronal) [Source:HGNC Symbol;Acc:1958]",0.0,1.0,0.6,0.6
489,489,CHRNA4,0.0005839892024484,PartialEpilepsy,ENSG00000101204,Tier 1,CHRNA4,20,61975420.0,62009753.0,-1.0,"cholinergic receptor, nicotinic, alpha 4 (neuronal) [Source:HGNC Symbol;Acc:1958]",0.0,1.0,0.6,0.6
491,491,BIRC3,0.0005810041926708,MigraineDisorder,ENSG00000023445,Tier 1,BIRC3,11,102188215.0,102210134.0,1.0,baculoviral IAP repeat containing 3 [Source:HGNC Symbol;Acc:591],0.0,1.0,0.6,0.6
492,492,SLC2A1,0.0005743518120274,MigraineDisorder,ENSG00000117394,Tier 2,SLC2A1,1,43391052.0,43424530.0,-1.0,"solute carrier family 2 (facilitated glucose transporter), member 1 [Source:HGNC Symbol;Acc:11005]",0.0,1.0,0.6,0.6
492,492,SLC2A1,0.0005743518120274,PartialEpilepsy,ENSG00000117394,Tier 2,SLC2A1,1,43391052.0,43424530.0,-1.0,"solute carrier family 2 (facilitated glucose transporter), member 1 [Source:HGNC Symbol;Acc:11005]",0.0,1.0,0.6,0.6
493,493,SLAMF1,0.0005707801972285,MS,ENSG00000117090,Tier 3A,SLAMF1,1,160577890.0,160617085.0,-1.0,signaling lymphocytic activation molecule family member 1 [Source:HGNC Symbol;Acc:10903],0.0,0.6,1.0,0.6
496,496,FLOT1,0.0005700896201308,UnipolarDepression,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05
497,497,ADGRL1,0.0005641154512194,AD,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05
511,511,JAM3,0.0005519137306923,Schizophrenia,ENSG00000166086,Tier 3B,JAM3,11,133938820.0,134021896.0,1.0,junctional adhesion molecule 3 [Source:HGNC Symbol;Acc:15532],0.0,0.6,1.0,0.6
514,514,GRIN1,0.000549486873566,PartialEpilepsy,ENSG00000176884,Tier 1,GRIN1,9,140032842.0,140063207.0,1.0,"glutamate receptor, ionotropic, N-methyl D-aspartate 1 [Source:HGNC Symbol;Acc:4584]",0.0,1.0,0.6,0.6
517,517,SLC12A5,0.0005464405696948,BipolarDisorder,ENSG00000124140,Tier 2,SLC12A5,20,44650356.0,44688784.0,1.0,"solute carrier family 12 (potassium/chloride transporter), member 5 [Source:HGNC Symbol;Acc:13818]",7.0,1.0,0.6,0.6
517,517,SLC12A5,0.0005464405696948,MajorDepressiveDisorder,ENSG00000124140,Tier 2,SLC12A5,20,44650356.0,44688784.0,1.0,"solute carrier family 12 (potassium/chloride transporter), member 5 [Source:HGNC Symbol;Acc:13818]",7.0,1.0,0.6,0.6
517,517,SLC12A5,0.0005464405696948,MS,ENSG00000124140,Tier 2,SLC12A5,20,44650356.0,44688784.0,1.0,"solute carrier family 12 (potassium/chloride transporter), member 5 [Source:HGNC Symbol;Acc:13818]",7.0,1.0,0.6,0.6
517,517,SLC12A5,0.0005464405696948,Schizophrenia,ENSG00000124140,Tier 2,SLC12A5,20,44650356.0,44688784.0,1.0,"solute carrier family 12 (potassium/chloride transporter), member 5 [Source:HGNC Symbol;Acc:13818]",7.0,1.0,0.6,0.6
517,517,SLC12A5,0.0005464405696948,UnipolarDepression,ENSG00000124140,Tier 2,SLC12A5,20,44650356.0,44688784.0,1.0,"solute carrier family 12 (potassium/chloride transporter), member 5 [Source:HGNC Symbol;Acc:13818]",7.0,1.0,0.6,0.6
519,519,SCN2A,0.0005456370575732,BipolarDisorder,ENSG00000136531,Tier 1,SCN2A,2,166095912.0,166248818.0,1.0,"sodium channel, voltage-gated, type II, alpha subunit [Source:HGNC Symbol;Acc:10588]",1.0,1.0,0.6,0.6
519,519,SCN2A,0.0005456370575732,PartialEpilepsy,ENSG00000136531,Tier 1,SCN2A,2,166095912.0,166248818.0,1.0,"sodium channel, voltage-gated, type II, alpha subunit [Source:HGNC Symbol;Acc:10588]",1.0,1.0,0.6,0.6
519,519,SCN2A,0.0005456370575732,PD,ENSG00000136531,Tier 1,SCN2A,2,166095912.0,166248818.0,1.0,"sodium channel, voltage-gated, type II, alpha subunit [Source:HGNC Symbol;Acc:10588]",1.0,1.0,0.6,0.6
520,520,SCN3A,0.0005456370575732,BipolarDisorder,ENSG00000153253,Tier 1,SCN3A,2,165944032.0,166060577.0,-1.0,"sodium channel, voltage-gated, type III, alpha subunit [Source:HGNC Symbol;Acc:10590]",0.0,1.0,0.6,0.6
520,520,SCN3A,0.0005456370575732,PartialEpilepsy,ENSG00000153253,Tier 1,SCN3A,2,165944032.0,166060577.0,-1.0,"sodium channel, voltage-gated, type III, alpha subunit [Source:HGNC Symbol;Acc:10590]",0.0,1.0,0.6,0.6
520,520,SCN3A,0.0005456370575732,PD,ENSG00000153253,Tier 1,SCN3A,2,165944032.0,166060577.0,-1.0,"sodium channel, voltage-gated, type III, alpha subunit [Source:HGNC Symbol;Acc:10590]",0.0,1.0,0.6,0.6
521,521,SCN1A,0.0005456370575732,MigraineDisorder,ENSG00000144285,Tier 1,SCN1A,2,166845670.0,166984523.0,-1.0,"sodium channel, voltage-gated, type I, alpha subunit [Source:HGNC Symbol;Acc:10585]",6.0,1.0,0.6,0.6
521,521,SCN1A,0.0005456370575732,MigraineWithAura,ENSG00000144285,Tier 1,SCN1A,2,166845670.0,166984523.0,-1.0,"sodium channel, voltage-gated, type I, alpha subunit [Source:HGNC Symbol;Acc:10585]",6.0,1.0,0.6,0.6
521,521,SCN1A,0.0005456370575732,PartialEpilepsy,ENSG00000144285,Tier 1,SCN1A,2,166845670.0,166984523.0,-1.0,"sodium channel, voltage-gated, type I, alpha subunit [Source:HGNC Symbol;Acc:10585]",6.0,1.0,0.6,0.6
522,522,TNFSF4,0.000545195192485,NarcolepsyCataplexy,ENSG00000117586,Tier 1,TNFSF4,1,173152873.0,173176452.0,-1.0,"tumor necrosis factor (ligand) superfamily, member 4 [Source:HGNC Symbol;Acc:11934]",2.0,0.6,1.0,0.6
522,522,TNFSF4,0.000545195192485,Narcolepsy,ENSG00000117586,Tier 1,TNFSF4,1,173152873.0,173176452.0,-1.0,"tumor necrosis factor (ligand) superfamily, member 4 [Source:HGNC Symbol;Acc:11934]",2.0,0.6,1.0,0.6
523,523,PAM,0.0005438565477673,PD,ENSG00000145730,Tier 2,PAM,5,102089685.0,102366809.0,1.0,peptidylglycine alpha-amidating monooxygenase [Source:HGNC Symbol;Acc:8596],0.0,1.0,1.0,0.6
530,530,SCARB1,0.0005387000761161,AD,ENSG00000073060,Tier 2,SCARB1,12,125261402.0,125367214.0,-1.0,"scavenger receptor class B, member 1 [Source:HGNC Symbol;Acc:1664]",6.0,1.0,0.6,0.6
550,550,GPC5,0.0005312657817182,Schizophrenia,ENSG00000179399,Tier 3A,GPC5,13,92050929.0,93519490.0,1.0,glypican 5 [Source:HGNC Symbol;Acc:4453],3.0,0.6,1.0,0.6
556,556,CD53,0.0005263846090915,Schizophrenia,ENSG00000143119,Tier 3A,CD53,1,111415775.0,111442550.0,1.0,CD53 molecule [Source:HGNC Symbol;Acc:1686],0.0,0.6,1.0,0.6
570,570,EP300,0.0005211634548726,AnorexiaNervosa,ENSG00000100393,Tier 2,EP300,22,41487790.0,41576081.0,1.0,E1A binding protein p300 [Source:HGNC Symbol;Acc:3373],1.0,1.0,0.6,0.6
570,570,EP300,0.0005211634548726,BipolarDisorder,ENSG00000100393,Tier 2,EP300,22,41487790.0,41576081.0,1.0,E1A binding protein p300 [Source:HGNC Symbol;Acc:3373],1.0,1.0,0.6,0.6
570,570,EP300,0.0005211634548726,OCD,ENSG00000100393,Tier 2,EP300,22,41487790.0,41576081.0,1.0,E1A binding protein p300 [Source:HGNC Symbol;Acc:3373],1.0,1.0,0.6,0.6
570,570,EP300,0.0005211634548726,Schizophrenia,ENSG00000100393,Tier 2,EP300,22,41487790.0,41576081.0,1.0,E1A binding protein p300 [Source:HGNC Symbol;Acc:3373],1.0,1.0,0.6,0.6
570,570,EP300,0.0005211634548726,TouretteSyndrome,ENSG00000100393,Tier 2,EP300,22,41487790.0,41576081.0,1.0,E1A binding protein p300 [Source:HGNC Symbol;Acc:3373],1.0,1.0,0.6,0.6
570,570,EP300,0.0005211634548726,UnipolarDepression,ENSG00000100393,Tier 2,EP300,22,41487790.0,41576081.0,1.0,E1A binding protein p300 [Source:HGNC Symbol;Acc:3373],1.0,1.0,0.6,0.6
577,577,BCL6,0.0005205977698162,MS,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05
596,596,IL22RA2,0.0005127222061521,MS,ENSG00000164485,Tier 3A,IL22RA2,6,137464968.0,137494785.0,-1.0,"interleukin 22 receptor, alpha 2 [Source:HGNC Symbol;Acc:14901]",0.0,0.6,1.0,0.6
597,597,LPP,0.000510316448978,MS,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05
597,597,LPP,0.000510316448978,Schizophrenia,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05
605,605,TEC,0.0004995153932227,MS,ENSG00000135605,Tier 1,TEC,4,48137800.0,48271881.0,-1.0,tec protein tyrosine kinase [Source:HGNC Symbol;Acc:11719],1.0,1.0,0.6,0.6
606,606,CTSB,0.0004991025491536,PD,ENSG00000164733,Tier 1,CTSB,8,11700033.0,11726957.0,-1.0,cathepsin B [Source:HGNC Symbol;Acc:2527],0.0,1.0,0.6,0.6
611,611,BLK,0.0004968074676346,UnipolarDepression,ENSG00000136573,Tier 1,BLK,8,11351510.0,11422113.0,1.0,B lymphoid tyrosine kinase [Source:HGNC Symbol;Acc:1057],11.0,1.0,0.6,0.6
617,617,IL5RA,0.000489834930214,RestlessLeg,ENSG00000091181,Tier 1,IL5RA,3,3111233.0,3168297.0,-1.0,"interleukin 5 receptor, alpha [Source:HGNC Symbol;Acc:6017]",0.0,0.6,1.0,0.6
620,620,CR1,0.0004813171094576,AD,ENSG00000203710,Tier 3A,CR1,1,207669492.0,207813992.0,1.0,complement component (3b/4b) receptor 1 (Knops blood group) [Source:HGNC Symbol;Acc:2334],8.0,0.6,1.0,0.6
621,621,HDAC4,0.0004812609503496,BrainAneurysm,ENSG00000068024,Tier 1,HDAC4,2,239969864.0,240323348.0,-1.0,histone deacetylase 4 [Source:HGNC Symbol;Acc:14063],0.0,1.0,0.6,0.6
647,647,CHRNA3,0.0004447970530855,ALS,ENSG00000080644,Tier 1,CHRNA3,15,78885394.0,78913637.0,-1.0,"cholinergic receptor, nicotinic, alpha 3 (neuronal) [Source:HGNC Symbol;Acc:1957]",28.0,1.0,0.6,0.6
647,647,CHRNA3,0.0004447970530855,AnorexiaNervosa,ENSG00000080644,Tier 1,CHRNA3,15,78885394.0,78913637.0,-1.0,"cholinergic receptor, nicotinic, alpha 3 (neuronal) [Source:HGNC Symbol;Acc:1957]",28.0,1.0,0.6,0.6
647,647,CHRNA3,0.0004447970530855,BipolarDisorder,ENSG00000080644,Tier 1,CHRNA3,15,78885394.0,78913637.0,-1.0,"cholinergic receptor, nicotinic, alpha 3 (neuronal) [Source:HGNC Symbol;Acc:1957]",28.0,1.0,0.6,0.6
647,647,CHRNA3,0.0004447970530855,BrainAneurysm,ENSG00000080644,Tier 1,CHRNA3,15,78885394.0,78913637.0,-1.0,"cholinergic receptor, nicotinic, alpha 3 (neuronal) [Source:HGNC Symbol;Acc:1957]",28.0,1.0,0.6,0.6
647,647,CHRNA3,0.0004447970530855,OCD,ENSG00000080644,Tier 1,CHRNA3,15,78885394.0,78913637.0,-1.0,"cholinergic receptor, nicotinic, alpha 3 (neuronal) [Source:HGNC Symbol;Acc:1957]",28.0,1.0,0.6,0.6
647,647,CHRNA3,0.0004447970530855,Schizophrenia,ENSG00000080644,Tier 1,CHRNA3,15,78885394.0,78913637.0,-1.0,"cholinergic receptor, nicotinic, alpha 3 (neuronal) [Source:HGNC Symbol;Acc:1957]",28.0,1.0,0.6,0.6
647,647,CHRNA3,0.0004447970530855,TouretteSyndrome,ENSG00000080644,Tier 1,CHRNA3,15,78885394.0,78913637.0,-1.0,"cholinergic receptor, nicotinic, alpha 3 (neuronal) [Source:HGNC Symbol;Acc:1957]",28.0,1.0,0.6,0.6
647,647,CHRNA3,0.0004447970530855,UnipolarDepression,ENSG00000080644,Tier 1,CHRNA3,15,78885394.0,78913637.0,-1.0,"cholinergic receptor, nicotinic, alpha 3 (neuronal) [Source:HGNC Symbol;Acc:1957]",28.0,1.0,0.6,0.6
648,648,CHRNB4,0.0004447970530855,ALS,ENSG00000117971,Tier 1,CHRNB4,15,78916461.0,79020096.0,-1.0,"cholinergic receptor, nicotinic, beta 4 (neuronal) [Source:HGNC Symbol;Acc:1964]",30.0,1.0,0.6,0.6
648,648,CHRNB4,0.0004447970530855,AnorexiaNervosa,ENSG00000117971,Tier 1,CHRNB4,15,78916461.0,79020096.0,-1.0,"cholinergic receptor, nicotinic, beta 4 (neuronal) [Source:HGNC Symbol;Acc:1964]",30.0,1.0,0.6,0.6
648,648,CHRNB4,0.0004447970530855,BipolarDisorder,ENSG00000117971,Tier 1,CHRNB4,15,78916461.0,79020096.0,-1.0,"cholinergic receptor, nicotinic, beta 4 (neuronal) [Source:HGNC Symbol;Acc:1964]",30.0,1.0,0.6,0.6
648,648,CHRNB4,0.0004447970530855,FrontotemporalDementia,ENSG00000117971,Tier 1,CHRNB4,15,78916461.0,79020096.0,-1.0,"cholinergic receptor, nicotinic, beta 4 (neuronal) [Source:HGNC Symbol;Acc:1964]",30.0,1.0,0.6,0.6
648,648,CHRNB4,0.0004447970530855,Schizophrenia,ENSG00000117971,Tier 1,CHRNB4,15,78916461.0,79020096.0,-1.0,"cholinergic receptor, nicotinic, beta 4 (neuronal) [Source:HGNC Symbol;Acc:1964]",30.0,1.0,0.6,0.6
649,649,CHRNB2,0.0004447970530855,PartialEpilepsy,ENSG00000160716,Tier 1,CHRNB2,1,154540257.0,154552502.0,1.0,"cholinergic receptor, nicotinic, beta 2 (neuronal) [Source:HGNC Symbol;Acc:1962]",0.0,1.0,1.0,0.6
650,650,CHRNB1,0.0004447970530855,PD,ENSG00000170175,Tier 1,CHRNB1,17,7348380.0,7361026.0,1.0,"cholinergic receptor, nicotinic, beta 1 (muscle) [Source:HGNC Symbol;Acc:1961]",0.0,1.0,1.0,0.6
651,651,CHRNA5,0.0004447970530855,AnorexiaNervosa,ENSG00000169684,Tier 2,CHRNA5,15,78857862.0,78887611.0,1.0,"cholinergic receptor, nicotinic, alpha 5 (neuronal) [Source:HGNC Symbol;Acc:1959]",27.0,1.0,0.6,0.6
651,651,CHRNA5,0.0004447970530855,BipolarDisorder,ENSG00000169684,Tier 2,CHRNA5,15,78857862.0,78887611.0,1.0,"cholinergic receptor, nicotinic, alpha 5 (neuronal) [Source:HGNC Symbol;Acc:1959]",27.0,1.0,0.6,0.6
651,651,CHRNA5,0.0004447970530855,BrainAneurysm,ENSG00000169684,Tier 2,CHRNA5,15,78857862.0,78887611.0,1.0,"cholinergic receptor, nicotinic, alpha 5 (neuronal) [Source:HGNC Symbol;Acc:1959]",27.0,1.0,0.6,0.6
651,651,CHRNA5,0.0004447970530855,OCD,ENSG00000169684,Tier 2,CHRNA5,15,78857862.0,78887611.0,1.0,"cholinergic receptor, nicotinic, alpha 5 (neuronal) [Source:HGNC Symbol;Acc:1959]",27.0,1.0,0.6,0.6
651,651,CHRNA5,0.0004447970530855,Schizophrenia,ENSG00000169684,Tier 2,CHRNA5,15,78857862.0,78887611.0,1.0,"cholinergic receptor, nicotinic, alpha 5 (neuronal) [Source:HGNC Symbol;Acc:1959]",27.0,1.0,0.6,0.6
651,651,CHRNA5,0.0004447970530855,TouretteSyndrome,ENSG00000169684,Tier 2,CHRNA5,15,78857862.0,78887611.0,1.0,"cholinergic receptor, nicotinic, alpha 5 (neuronal) [Source:HGNC Symbol;Acc:1959]",27.0,1.0,0.6,0.6
651,651,CHRNA5,0.0004447970530855,UnipolarDepression,ENSG00000169684,Tier 2,CHRNA5,15,78857862.0,78887611.0,1.0,"cholinergic receptor, nicotinic, alpha 5 (neuronal) [Source:HGNC Symbol;Acc:1959]",27.0,1.0,0.6,0.6
652,652,CHRNA9,0.0004447970530855,MS,ENSG00000174343,Tier 3A,CHRNA9,4,40337346.0,40357234.0,1.0,"cholinergic receptor, nicotinic, alpha 9 (neuronal) [Source:HGNC Symbol;Acc:14079]",0.0,1.0,0.6,0.6
653,653,CHRNA2,0.0004447970530855,AD,ENSG00000120903,Tier 1,CHRNA2,8,27317279.0,27337400.0,-1.0,"cholinergic receptor, nicotinic, alpha 2 (neuronal) [Source:HGNC Symbol;Acc:1956]",0.0,1.0,1.0,0.6
653,653,CHRNA2,0.0004447970530855,PartialEpilepsy,ENSG00000120903,Tier 1,CHRNA2,8,27317279.0,27337400.0,-1.0,"cholinergic receptor, nicotinic, alpha 2 (neuronal) [Source:HGNC Symbol;Acc:1956]",0.0,1.0,1.0,0.6
653,653,CHRNA2,0.0004447970530855,Schizophrenia,ENSG00000120903,Tier 1,CHRNA2,8,27317279.0,27337400.0,-1.0,"cholinergic receptor, nicotinic, alpha 2 (neuronal) [Source:HGNC Symbol;Acc:1956]",0.0,1.0,1.0,0.6
673,673,NCAM2,0.0004340068498828,AnorexiaNervosa,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05
673,673,NCAM2,0.0004340068498828,Schizophrenia,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05
674,674,GRM5,0.0004339414948713,BipolarDisorder,ENSG00000168959,Tier 1,GRM5,11,88237744.0,88799113.0,-1.0,"glutamate receptor, metabotropic 5 [Source:HGNC Symbol;Acc:4597]",10.0,1.0,0.6,0.6
674,674,GRM5,0.0004339414948713,MajorDepressiveDisorder,ENSG00000168959,Tier 1,GRM5,11,88237744.0,88799113.0,-1.0,"glutamate receptor, metabotropic 5 [Source:HGNC Symbol;Acc:4597]",10.0,1.0,0.6,0.6
674,674,GRM5,0.0004339414948713,NeuroticDisorder,ENSG00000168959,Tier 1,GRM5,11,88237744.0,88799113.0,-1.0,"glutamate receptor, metabotropic 5 [Source:HGNC Symbol;Acc:4597]",10.0,1.0,0.6,0.6
674,674,GRM5,0.0004339414948713,UnipolarDepression,ENSG00000168959,Tier 1,GRM5,11,88237744.0,88799113.0,-1.0,"glutamate receptor, metabotropic 5 [Source:HGNC Symbol;Acc:4597]",10.0,1.0,0.6,0.6
678,678,TNFSF18,0.000431428591274,NarcolepsyCataplexy,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05
678,678,TNFSF18,0.000431428591274,Narcolepsy,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05
688,688,ESR2,0.0004277600604565,AnorexiaNervosa,ENSG00000140009,Tier 1,ESR2,14,64550950.0,64804830.0,-1.0,estrogen receptor 2 (ER beta) [Source:HGNC Symbol;Acc:3468],1.0,1.0,0.6,0.6
688,688,ESR2,0.0004277600604565,BipolarDisorder,ENSG00000140009,Tier 1,ESR2,14,64550950.0,64804830.0,-1.0,estrogen receptor 2 (ER beta) [Source:HGNC Symbol;Acc:3468],1.0,1.0,0.6,0.6
688,688,ESR2,0.0004277600604565,MajorDepressiveDisorder,ENSG00000140009,Tier 1,ESR2,14,64550950.0,64804830.0,-1.0,estrogen receptor 2 (ER beta) [Source:HGNC Symbol;Acc:3468],1.0,1.0,0.6,0.6
688,688,ESR2,0.0004277600604565,OCD,ENSG00000140009,Tier 1,ESR2,14,64550950.0,64804830.0,-1.0,estrogen receptor 2 (ER beta) [Source:HGNC Symbol;Acc:3468],1.0,1.0,0.6,0.6
688,688,ESR2,0.0004277600604565,Schizophrenia,ENSG00000140009,Tier 1,ESR2,14,64550950.0,64804830.0,-1.0,estrogen receptor 2 (ER beta) [Source:HGNC Symbol;Acc:3468],1.0,1.0,0.6,0.6
688,688,ESR2,0.0004277600604565,TouretteSyndrome,ENSG00000140009,Tier 1,ESR2,14,64550950.0,64804830.0,-1.0,estrogen receptor 2 (ER beta) [Source:HGNC Symbol;Acc:3468],1.0,1.0,0.6,0.6
688,688,ESR2,0.0004277600604565,UnipolarDepression,ENSG00000140009,Tier 1,ESR2,14,64550950.0,64804830.0,-1.0,estrogen receptor 2 (ER beta) [Source:HGNC Symbol;Acc:3468],1.0,1.0,0.6,0.6
691,691,ADGRL2,0.0004246923807803,Schizophrenia,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05
694,694,ANG,0.0004227127712965,ALS,ENSG00000214274,Tier 3B,ANG,14,21152336.0,21167130.0,1.0,"angiogenin, ribonuclease, RNase A family, 5 [Source:HGNC Symbol;Acc:483]",0.0,0.6,1.0,0.6
694,694,ANG,0.0004227127712965,FrontotemporalDementia,ENSG00000214274,Tier 3B,ANG,14,21152336.0,21167130.0,1.0,"angiogenin, ribonuclease, RNase A family, 5 [Source:HGNC Symbol;Acc:483]",0.0,0.6,1.0,0.6
698,698,ADCY3,0.000419005857885,MS,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05
708,708,CAMK2G,0.0004155227933418,MS,ENSG00000148660,Tier 1,CAMK2G,10,75572259.0,75634343.0,-1.0,calcium/calmodulin-dependent protein kinase II gamma [Source:HGNC Symbol;Acc:1463],2.0,1.0,0.6,0.6
709,709,CAMK2D,0.0004155227933418,PD,ENSG00000145349,Tier 1,CAMK2D,4,114372188.0,114683083.0,-1.0,calcium/calmodulin-dependent protein kinase II delta [Source:HGNC Symbol;Acc:1462],1.0,1.0,0.6,0.6
712,712,IFNK,0.0004140820733861,ALS,ENSG00000147896,Tier 3A,IFNK,9,27524312.0,27526496.0,1.0,"interferon, kappa [Source:HGNC Symbol;Acc:21714]",8.0,0.6,1.0,0.6
713,713,IL34,0.0004140681297682,AD,ENSG00000157368,Tier 3B,IL34,16,70613798.0,70694585.0,1.0,interleukin 34 [Source:HGNC Symbol;Acc:28529],0.0,0.6,1.0,0.6
717,717,VANGL2,0.0004125399266397,MS,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05
718,718,RORA,0.0004125399266397,AnorexiaNervosa,ENSG00000069667,Tier 3A,RORA,15,60780483.0,61521518.0,-1.0,RAR-related orphan receptor A [Source:HGNC Symbol;Acc:10258],5.0,1.0,0.6,0.6
718,718,RORA,0.0004125399266397,BipolarDisorder,ENSG00000069667,Tier 3A,RORA,15,60780483.0,61521518.0,-1.0,RAR-related orphan receptor A [Source:HGNC Symbol;Acc:10258],5.0,1.0,0.6,0.6
718,718,RORA,0.0004125399266397,MS,ENSG00000069667,Tier 3A,RORA,15,60780483.0,61521518.0,-1.0,RAR-related orphan receptor A [Source:HGNC Symbol;Acc:10258],5.0,1.0,0.6,0.6
718,718,RORA,0.0004125399266397,OCD,ENSG00000069667,Tier 3A,RORA,15,60780483.0,61521518.0,-1.0,RAR-related orphan receptor A [Source:HGNC Symbol;Acc:10258],5.0,1.0,0.6,0.6
718,718,RORA,0.0004125399266397,Schizophrenia,ENSG00000069667,Tier 3A,RORA,15,60780483.0,61521518.0,-1.0,RAR-related orphan receptor A [Source:HGNC Symbol;Acc:10258],5.0,1.0,0.6,0.6
718,718,RORA,0.0004125399266397,TouretteSyndrome,ENSG00000069667,Tier 3A,RORA,15,60780483.0,61521518.0,-1.0,RAR-related orphan receptor A [Source:HGNC Symbol;Acc:10258],5.0,1.0,0.6,0.6
718,718,RORA,0.0004125399266397,UnipolarDepression,ENSG00000069667,Tier 3A,RORA,15,60780483.0,61521518.0,-1.0,RAR-related orphan receptor A [Source:HGNC Symbol;Acc:10258],5.0,1.0,0.6,0.6
728,728,SMPD3,0.0004093466694797,Schizophrenia,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05
732,732,GPR151,0.0004090749371548,EssentialTremor,ENSG00000173250,Tier 3B,GPR151,5,145892666.0,145895753.0,-1.0,G protein-coupled receptor 151 [Source:HGNC Symbol;Acc:23624],0.0,1.0,0.6,0.6
751,751,SPON1,0.0004024682761509,AD,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05
752,752,RTN4R,0.0004019822871862,Schizophrenia,ENSG00000040608,Tier 3A,RTN4R,22,20228938.0,20270769.0,-1.0,reticulon 4 receptor [Source:HGNC Symbol;Acc:18601],0.0,1.0,1.0,0.6
759,759,ACE,0.0003989173271295,AD,ENSG00000159640,Tier 1,ACE,17,61554422.0,61599205.0,1.0,angiotensin I converting enzyme [Source:HGNC Symbol;Acc:2707],13.0,1.0,1.0,0.6
759,759,ACE,0.0003989173271295,IntracranialHemorrhage,ENSG00000159640,Tier 1,ACE,17,61554422.0,61599205.0,1.0,angiotensin I converting enzyme [Source:HGNC Symbol;Acc:2707],13.0,1.0,1.0,0.6
760,760,PRKAG1,0.0003980706328755,BipolarDisorder,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05
768,768,NOX4,0.0003943192916286,AnorexiaNervosa,ENSG00000086991,Tier 2,NOX4,11,89057524.0,89322779.0,-1.0,NADPH oxidase 4 [Source:HGNC Symbol;Acc:7891],11.0,1.0,0.6,0.6
768,768,NOX4,0.0003943192916286,BipolarDisorder,ENSG00000086991,Tier 2,NOX4,11,89057524.0,89322779.0,-1.0,NADPH oxidase 4 [Source:HGNC Symbol;Acc:7891],11.0,1.0,0.6,0.6
768,768,NOX4,0.0003943192916286,OCD,ENSG00000086991,Tier 2,NOX4,11,89057524.0,89322779.0,-1.0,NADPH oxidase 4 [Source:HGNC Symbol;Acc:7891],11.0,1.0,0.6,0.6
768,768,NOX4,0.0003943192916286,Schizophrenia,ENSG00000086991,Tier 2,NOX4,11,89057524.0,89322779.0,-1.0,NADPH oxidase 4 [Source:HGNC Symbol;Acc:7891],11.0,1.0,0.6,0.6
768,768,NOX4,0.0003943192916286,TouretteSyndrome,ENSG00000086991,Tier 2,NOX4,11,89057524.0,89322779.0,-1.0,NADPH oxidase 4 [Source:HGNC Symbol;Acc:7891],11.0,1.0,0.6,0.6
768,768,NOX4,0.0003943192916286,UnipolarDepression,ENSG00000086991,Tier 2,NOX4,11,89057524.0,89322779.0,-1.0,NADPH oxidase 4 [Source:HGNC Symbol;Acc:7891],11.0,1.0,0.6,0.6
777,777,CASP1,0.0003913033529969,Schizophrenia,ENSG00000137752,Tier 1,CASP1,11,104896170.0,104972158.0,-1.0,"caspase 1, apoptosis-related cysteine peptidase [Source:HGNC Symbol;Acc:1499]",0.0,1.0,0.6,0.6
781,781,STK4,0.0003899505009865,BipolarDisorder,ENSG00000101109,Tier 1,STK4,20,43595115.0,43708600.0,1.0,serine/threonine kinase 4 [Source:HGNC Symbol;Acc:11408],0.0,1.0,0.6,0.6
781,781,STK4,0.0003899505009865,UnipolarDepression,ENSG00000101109,Tier 1,STK4,20,43595115.0,43708600.0,1.0,serine/threonine kinase 4 [Source:HGNC Symbol;Acc:11408],0.0,1.0,0.6,0.6
785,785,CD6,0.0003889148836062,MS,ENSG00000013725,Tier 1,CD6,11,60739115.0,60787849.0,1.0,CD6 molecule [Source:HGNC Symbol;Acc:1691],3.0,0.6,1.0,0.6
796,796,CMKLR1,0.0003812777349423,Schizophrenia,ENSG00000174600,Tier 2,CMKLR1,12,108681821.0,108733118.0,-1.0,chemokine-like receptor 1 [Source:HGNC Symbol;Acc:2121],0.0,1.0,1.0,0.6
807,807,STK39,0.0003750577394489,PD,ENSG00000198648,Tier 2,STK39,2,168810530.0,169104651.0,-1.0,serine threonine kinase 39 [Source:HGNC Symbol;Acc:17717],2.0,1.0,0.6,0.6
809,809,MAPKAPK3,0.0003734087404585,Schizophrenia,ENSG00000114738,Tier 2,MAPKAPK3,3,50648951.0,50686720.0,1.0,mitogen-activated protein kinase-activated protein kinase 3 [Source:HGNC Symbol;Acc:6888],1.0,1.0,0.6,0.6
810,810,TBK1,0.0003734087404585,ALS,ENSG00000183735,Tier 1,TBK1,12,64845660.0,64895888.0,1.0,TANK-binding kinase 1 [Source:HGNC Symbol;Acc:11584],0.0,1.0,0.6,0.6
810,810,TBK1,0.0003734087404585,FrontotemporalDementia,ENSG00000183735,Tier 1,TBK1,12,64845660.0,64895888.0,1.0,TANK-binding kinase 1 [Source:HGNC Symbol;Acc:11584],0.0,1.0,0.6,0.6
815,815,CTSS,0.0003720807231428,Schizophrenia,ENSG00000163131,Tier 1,CTSS,1,150702672.0,150738433.0,-1.0,cathepsin S [Source:HGNC Symbol;Acc:2545],5.0,1.0,0.6,0.6
817,817,ADAMTS4,0.0003708693357448,AD,ENSG00000158859,Tier 2,ADAMTS4,1,161154098.0,161168846.0,-1.0,"ADAM metallopeptidase with thrombospondin type 1 motif, 4 [Source:HGNC Symbol;Acc:220]",0.0,1.0,1.0,0.6
819,819,MOG,0.0003692030242934,NarcolepsyCataplexy,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05
819,819,MOG,0.0003692030242934,Narcolepsy,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05
819,819,MOG,0.0003692030242934,Schizophrenia,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05
820,820,HDAC5,0.0003685001862034,BipolarDisorder,ENSG00000108840,Tier 1,HDAC5,17,42154114.0,42201070.0,-1.0,histone deacetylase 5 [Source:HGNC Symbol;Acc:14068],3.0,1.0,0.6,0.6
824,824,FURIN,0.0003676868996731,AnorexiaNervosa,ENSG00000140564,Tier 3A,FURIN,15,91411822.0,91426688.0,1.0,furin (paired basic amino acid cleaving enzyme) [Source:HGNC Symbol;Acc:8568],4.0,0.6,1.0,0.6
824,824,FURIN,0.0003676868996731,BipolarDisorder,ENSG00000140564,Tier 3A,FURIN,15,91411822.0,91426688.0,1.0,furin (paired basic amino acid cleaving enzyme) [Source:HGNC Symbol;Acc:8568],4.0,0.6,1.0,0.6
824,824,FURIN,0.0003676868996731,MajorDepressiveDisorder,ENSG00000140564,Tier 3A,FURIN,15,91411822.0,91426688.0,1.0,furin (paired basic amino acid cleaving enzyme) [Source:HGNC Symbol;Acc:8568],4.0,0.6,1.0,0.6
824,824,FURIN,0.0003676868996731,OCD,ENSG00000140564,Tier 3A,FURIN,15,91411822.0,91426688.0,1.0,furin (paired basic amino acid cleaving enzyme) [Source:HGNC Symbol;Acc:8568],4.0,0.6,1.0,0.6
824,824,FURIN,0.0003676868996731,Schizophrenia,ENSG00000140564,Tier 3A,FURIN,15,91411822.0,91426688.0,1.0,furin (paired basic amino acid cleaving enzyme) [Source:HGNC Symbol;Acc:8568],4.0,0.6,1.0,0.6
824,824,FURIN,0.0003676868996731,TouretteSyndrome,ENSG00000140564,Tier 3A,FURIN,15,91411822.0,91426688.0,1.0,furin (paired basic amino acid cleaving enzyme) [Source:HGNC Symbol;Acc:8568],4.0,0.6,1.0,0.6
824,824,FURIN,0.0003676868996731,UnipolarDepression,ENSG00000140564,Tier 3A,FURIN,15,91411822.0,91426688.0,1.0,furin (paired basic amino acid cleaving enzyme) [Source:HGNC Symbol;Acc:8568],4.0,0.6,1.0,0.6
827,827,PON1,0.0003674961509441,ALS,ENSG00000005421,Tier 1,PON1,7,94926988.0,95025673.0,-1.0,paraoxonase 1 [Source:HGNC Symbol;Acc:9204],3.0,0.6,1.0,1.0
833,833,HDC,0.0003644737489792,TouretteSyndrome,ENSG00000140287,Tier 2,HDC,15,50534144.0,50558223.0,-1.0,histidine decarboxylase [Source:HGNC Symbol;Acc:4855],0.0,1.0,0.6,0.6
835,835,PRKG1,0.000361392001358,Schizophrenia,ENSG00000185532,Tier 2,PRKG1,10,52750945.0,54058110.0,1.0,"protein kinase, cGMP-dependent, type I [Source:HGNC Symbol;Acc:9414]",1.0,1.0,0.6,0.6
860,860,PLCE1,0.0003452978787655,BrainAneurysm,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05
860,860,PLCE1,0.0003452978787655,MigraineDisorder,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05
875,875,LILRA5,0.0003349913873796,AD,ENSG00000187116,Tier 3A,LILRA5,19,54818353.0,54824409.0,-1.0,"leukocyte immunoglobulin-like receptor, subfamily A (with TM domain), member 5 [Source:HGNC Symbol;Acc:16309]",0.0,0.6,1.0,0.6
880,880,GPR25,0.0003247519735805,MS,ENSG00000170128,Tier 3B,GPR25,1,200842083.0,200843306.0,1.0,G protein-coupled receptor 25 [Source:HGNC Symbol;Acc:4480],1.0,1.0,1.0,0.6
889,889,BTN3A2,0.0003195710402147,BipolarDisorder,ENSG00000186470,Tier 3B,BTN3A2,6,26365387.0,26378546.0,1.0,"butyrophilin, subfamily 3, member A2 [Source:HGNC Symbol;Acc:1139]",0.0,0.6,1.0,0.6
889,889,BTN3A2,0.0003195710402147,MajorDepressiveDisorder,ENSG00000186470,Tier 3B,BTN3A2,6,26365387.0,26378546.0,1.0,"butyrophilin, subfamily 3, member A2 [Source:HGNC Symbol;Acc:1139]",0.0,0.6,1.0,0.6
889,889,BTN3A2,0.0003195710402147,Schizophrenia,ENSG00000186470,Tier 3B,BTN3A2,6,26365387.0,26378546.0,1.0,"butyrophilin, subfamily 3, member A2 [Source:HGNC Symbol;Acc:1139]",0.0,0.6,1.0,0.6
891,891,PPARA,0.0003178492756171,BipolarDisorder,ENSG00000186951,Tier 1,PPARA,22,46546424.0,46639653.0,1.0,peroxisome proliferator-activated receptor alpha [Source:HGNC Symbol;Acc:9232],2.0,1.0,0.6,1.0
891,891,PPARA,0.0003178492756171,MajorDepressiveDisorder,ENSG00000186951,Tier 1,PPARA,22,46546424.0,46639653.0,1.0,peroxisome proliferator-activated receptor alpha [Source:HGNC Symbol;Acc:9232],2.0,1.0,0.6,1.0
891,891,PPARA,0.0003178492756171,Schizophrenia,ENSG00000186951,Tier 1,PPARA,22,46546424.0,46639653.0,1.0,peroxisome proliferator-activated receptor alpha [Source:HGNC Symbol;Acc:9232],2.0,1.0,0.6,1.0
891,891,PPARA,0.0003178492756171,UnipolarDepression,ENSG00000186951,Tier 1,PPARA,22,46546424.0,46639653.0,1.0,peroxisome proliferator-activated receptor alpha [Source:HGNC Symbol;Acc:9232],2.0,1.0,0.6,1.0
892,892,THRB,0.0003178492756171,Schizophrenia,ENSG00000151090,Tier 1,THRB,3,24158651.0,24536773.0,-1.0,"thyroid hormone receptor, beta [Source:HGNC Symbol;Acc:11799]",3.0,1.0,0.6,0.6
893,893,THRA,0.0003178492756171,BipolarDisorder,ENSG00000126351,Tier 1,THRA,17,38214543.0,38250120.0,1.0,"thyroid hormone receptor, alpha [Source:HGNC Symbol;Acc:11796]",7.0,1.0,0.6,0.6
893,893,THRA,0.0003178492756171,MS,ENSG00000126351,Tier 1,THRA,17,38214543.0,38250120.0,1.0,"thyroid hormone receptor, alpha [Source:HGNC Symbol;Acc:11796]",7.0,1.0,0.6,0.6
893,893,THRA,0.0003178492756171,NeuroticDisorder,ENSG00000126351,Tier 1,THRA,17,38214543.0,38250120.0,1.0,"thyroid hormone receptor, alpha [Source:HGNC Symbol;Acc:11796]",7.0,1.0,0.6,0.6
894,894,NR1H3,0.0003178492756171,MS,ENSG00000025434,Tier 2,NR1H3,11,47269851.0,47290396.0,1.0,"nuclear receptor subfamily 1, group H, member 3 [Source:HGNC Symbol;Acc:7966]",11.0,1.0,0.6,0.6
908,908,HAVCR2,0.0003056657573383,AD,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05
912,912,CNTNAP2,0.0003018734315406,AD,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05
912,912,CNTNAP2,0.0003018734315406,PartialEpilepsy,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05
926,926,RPS6KA2,0.0002988500244952,BipolarDisorder,ENSG00000071242,Tier 1,RPS6KA2,6,166822852.0,167319939.0,-1.0,"ribosomal protein S6 kinase, 90kDa, polypeptide 2 [Source:HGNC Symbol;Acc:10431]",0.0,1.0,0.6,0.6
944,944,SLC10A2,0.0002907533847108,AD,ENSG00000125255,Tier 1,SLC10A2,13,103696350.0,103719196.0,-1.0,"solute carrier family 10 (sodium/bile acid cotransporter), member 2 [Source:HGNC Symbol;Acc:10906]",0.0,1.0,0.6,1.0
948,948,CYP17A1,0.0002904642427886,AnorexiaNervosa,ENSG00000148795,Tier 1,CYP17A1,10,104590288.0,104597290.0,-1.0,"cytochrome P450, family 17, subfamily A, polypeptide 1 [Source:HGNC Symbol;Acc:2593]",24.0,1.0,0.6,1.0
948,948,CYP17A1,0.0002904642427886,BipolarDisorder,ENSG00000148795,Tier 1,CYP17A1,10,104590288.0,104597290.0,-1.0,"cytochrome P450, family 17, subfamily A, polypeptide 1 [Source:HGNC Symbol;Acc:2593]",24.0,1.0,0.6,1.0
948,948,CYP17A1,0.0002904642427886,OCD,ENSG00000148795,Tier 1,CYP17A1,10,104590288.0,104597290.0,-1.0,"cytochrome P450, family 17, subfamily A, polypeptide 1 [Source:HGNC Symbol;Acc:2593]",24.0,1.0,0.6,1.0
948,948,CYP17A1,0.0002904642427886,Schizophrenia,ENSG00000148795,Tier 1,CYP17A1,10,104590288.0,104597290.0,-1.0,"cytochrome P450, family 17, subfamily A, polypeptide 1 [Source:HGNC Symbol;Acc:2593]",24.0,1.0,0.6,1.0
948,948,CYP17A1,0.0002904642427886,TouretteSyndrome,ENSG00000148795,Tier 1,CYP17A1,10,104590288.0,104597290.0,-1.0,"cytochrome P450, family 17, subfamily A, polypeptide 1 [Source:HGNC Symbol;Acc:2593]",24.0,1.0,0.6,1.0
948,948,CYP17A1,0.0002904642427886,UnipolarDepression,ENSG00000148795,Tier 1,CYP17A1,10,104590288.0,104597290.0,-1.0,"cytochrome P450, family 17, subfamily A, polypeptide 1 [Source:HGNC Symbol;Acc:2593]",24.0,1.0,0.6,1.0
959,959,IMPG2,0.0002869848704949,MS,ENSG00000081148,Tier 3B,IMPG2,3,100941390.0,101039404.0,-1.0,interphotoreceptor matrix proteoglycan 2 [Source:HGNC Symbol;Acc:18362],0.0,0.6,1.0,0.6
961,961,UNC5C,0.0002844886037848,AD,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05
982,982,APOC4,0.0002799870214217,AD,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05
983,983,CELSR3,0.0002795795415861,AnorexiaNervosa,ENSG00000008300,Tier 3B,CELSR3,3,48673902.0,48700348.0,-1.0,"cadherin, EGF LAG seven-pass G-type receptor 3 [Source:HGNC Symbol;Acc:3230]",0.0,0.6,1.0,0.6
983,983,CELSR3,0.0002795795415861,TouretteSyndrome,ENSG00000008300,Tier 3B,CELSR3,3,48673902.0,48700348.0,-1.0,"cadherin, EGF LAG seven-pass G-type receptor 3 [Source:HGNC Symbol;Acc:3230]",0.0,0.6,1.0,0.6
983,983,CELSR3,0.0002795795415861,UnipolarDepression,ENSG00000008300,Tier 3B,CELSR3,3,48673902.0,48700348.0,-1.0,"cadherin, EGF LAG seven-pass G-type receptor 3 [Source:HGNC Symbol;Acc:3230]",0.0,0.6,1.0,0.6
986,986,SCARF1,0.0002773946986027,BrainAneurysm,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05
1031,1031,ALPK3,0.0002666663682159,AnorexiaNervosa,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05
1031,1031,ALPK3,0.0002666663682159,BipolarDisorder,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05
1031,1031,ALPK3,0.0002666663682159,Schizophrenia,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05
1044,1044,FAM3B,0.0002653352192363,Schizophrenia,ENSG00000183844,Tier 3A,FAM3B,21,42676139.0,42729358.0,1.0,"family with sequence similarity 3, member B [Source:HGNC Symbol;Acc:1253]",2.0,0.6,1.0,0.6
1064,1064,TUBA4A,0.0002630863778969,ALS,ENSG00000127824,Tier 3B,TUBA4A,2,220114433.0,220142892.0,-1.0,"tubulin, alpha 4a [Source:HGNC Symbol;Acc:12407]",0.0,1.0,1.0,0.6
1067,1067,TNK2,0.0002630863778969,PD,ENSG00000061938,Tier 1,TNK2,3,195590235.0,195638816.0,-1.0,"tyrosine kinase, non-receptor, 2 [Source:HGNC Symbol;Acc:19297]",0.0,1.0,0.6,0.6
1069,1069,TXK,0.0002630863778969,MS,ENSG00000074966,Tier 1,TXK,4,48068410.0,48136273.0,-1.0,TXK tyrosine kinase [Source:HGNC Symbol;Acc:12434],0.0,1.0,0.6,0.6
1074,1074,AATK,0.0002630863778969,NeuroticDisorder,ENSG00000181409,Tier 3A,AATK,17,79091095.0,79139877.0,-1.0,apoptosis-associated tyrosine kinase [Source:HGNC Symbol;Acc:21],0.0,1.0,0.6,0.6
1074,1074,AATK,0.0002630863778969,UnipolarDepression,ENSG00000181409,Tier 3A,AATK,17,79091095.0,79139877.0,-1.0,apoptosis-associated tyrosine kinase [Source:HGNC Symbol;Acc:21],0.0,1.0,0.6,0.6
1099,1099,CD19,0.0002630863778969,PD,ENSG00000177455,Tier 1,CD19,16,28943260.0,28950667.0,1.0,CD19 molecule [Source:HGNC Symbol;Acc:1633],8.0,0.6,1.0,0.6
1103,1103,VRK1,0.0002621392982371,ALS,ENSG00000100749,Tier 3A,VRK1,14,97263641.0,97398059.0,1.0,vaccinia related kinase 1 [Source:HGNC Symbol;Acc:12718],0.0,1.0,0.6,0.6
1104,1104,VRK2,0.0002621392982371,AnorexiaNervosa,ENSG00000028116,Tier 1,VRK2,2,58134786.0,58387055.0,1.0,vaccinia related kinase 2 [Source:HGNC Symbol;Acc:12719],2.0,1.0,0.6,0.6
1104,1104,VRK2,0.0002621392982371,BipolarDisorder,ENSG00000028116,Tier 1,VRK2,2,58134786.0,58387055.0,1.0,vaccinia related kinase 2 [Source:HGNC Symbol;Acc:12719],2.0,1.0,0.6,0.6
1104,1104,VRK2,0.0002621392982371,MajorDepressiveDisorder,ENSG00000028116,Tier 1,VRK2,2,58134786.0,58387055.0,1.0,vaccinia related kinase 2 [Source:HGNC Symbol;Acc:12719],2.0,1.0,0.6,0.6
1104,1104,VRK2,0.0002621392982371,OCD,ENSG00000028116,Tier 1,VRK2,2,58134786.0,58387055.0,1.0,vaccinia related kinase 2 [Source:HGNC Symbol;Acc:12719],2.0,1.0,0.6,0.6
1104,1104,VRK2,0.0002621392982371,PartialEpilepsy,ENSG00000028116,Tier 1,VRK2,2,58134786.0,58387055.0,1.0,vaccinia related kinase 2 [Source:HGNC Symbol;Acc:12719],2.0,1.0,0.6,0.6
1104,1104,VRK2,0.0002621392982371,Schizophrenia,ENSG00000028116,Tier 1,VRK2,2,58134786.0,58387055.0,1.0,vaccinia related kinase 2 [Source:HGNC Symbol;Acc:12719],2.0,1.0,0.6,0.6
1104,1104,VRK2,0.0002621392982371,TouretteSyndrome,ENSG00000028116,Tier 1,VRK2,2,58134786.0,58387055.0,1.0,vaccinia related kinase 2 [Source:HGNC Symbol;Acc:12719],2.0,1.0,0.6,0.6
1104,1104,VRK2,0.0002621392982371,UnipolarDepression,ENSG00000028116,Tier 1,VRK2,2,58134786.0,58387055.0,1.0,vaccinia related kinase 2 [Source:HGNC Symbol;Acc:12719],2.0,1.0,0.6,0.6
1105,1105,ADGRB1,0.0002621392982371,BipolarDisorder,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05
1105,1105,ADGRB1,0.0002621392982371,Schizophrenia,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05
1106,1106,PLK2,0.0002621392982371,Schizophrenia,ENSG00000145632,Tier 2,PLK2,5,57749809.0,57756087.0,-1.0,polo-like kinase 2 [Source:HGNC Symbol;Acc:19699],0.0,1.0,0.6,0.6
1121,1121,CDH10,0.0002612926301903,AnorexiaNervosa,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05
1123,1123,TMEM219,0.0002590063545562,Schizophrenia,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05
1124,1124,MS4A4A,0.0002582820244802,AD,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05
1125,1125,ATP2A2,0.0002578374266461,AnorexiaNervosa,ENSG00000174437,Tier 3B,ATP2A2,12,110718561.0,110788898.0,1.0,"ATPase, Ca++ transporting, cardiac muscle, slow twitch 2 [Source:HGNC Symbol;Acc:812]",2.0,1.0,0.6,0.6
1125,1125,ATP2A2,0.0002578374266461,BipolarDisorder,ENSG00000174437,Tier 3B,ATP2A2,12,110718561.0,110788898.0,1.0,"ATPase, Ca++ transporting, cardiac muscle, slow twitch 2 [Source:HGNC Symbol;Acc:812]",2.0,1.0,0.6,0.6
1125,1125,ATP2A2,0.0002578374266461,OCD,ENSG00000174437,Tier 3B,ATP2A2,12,110718561.0,110788898.0,1.0,"ATPase, Ca++ transporting, cardiac muscle, slow twitch 2 [Source:HGNC Symbol;Acc:812]",2.0,1.0,0.6,0.6
1125,1125,ATP2A2,0.0002578374266461,Schizophrenia,ENSG00000174437,Tier 3B,ATP2A2,12,110718561.0,110788898.0,1.0,"ATPase, Ca++ transporting, cardiac muscle, slow twitch 2 [Source:HGNC Symbol;Acc:812]",2.0,1.0,0.6,0.6
1125,1125,ATP2A2,0.0002578374266461,TouretteSyndrome,ENSG00000174437,Tier 3B,ATP2A2,12,110718561.0,110788898.0,1.0,"ATPase, Ca++ transporting, cardiac muscle, slow twitch 2 [Source:HGNC Symbol;Acc:812]",2.0,1.0,0.6,0.6
1125,1125,ATP2A2,0.0002578374266461,UnipolarDepression,ENSG00000174437,Tier 3B,ATP2A2,12,110718561.0,110788898.0,1.0,"ATPase, Ca++ transporting, cardiac muscle, slow twitch 2 [Source:HGNC Symbol;Acc:812]",2.0,1.0,0.6,0.6
1128,1128,LRRN3,0.0002574245354793,Schizophrenia,ENSG00000173114,Tier 3B,LRRN3,7,110731062.0,110765510.0,1.0,leucine rich repeat neuronal 3 [Source:HGNC Symbol;Acc:17200],1.0,1.0,0.6,0.6
1132,1132,NOX3,0.000253372816416,Schizophrenia,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05
1141,1141,ADCY5,0.0002501332614882,PD,ENSG00000173175,Tier 1,ADCY5,3,123001143.0,123168605.0,-1.0,adenylate cyclase 5 [Source:HGNC Symbol;Acc:236],7.0,1.0,0.6,0.6
1142,1142,ADCY2,0.0002501332614882,BipolarDisorder,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05
1142,1142,ADCY2,0.0002501332614882,UnipolarDepression,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05
1170,1170,ZPBP2,0.0002496272132511,MS,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05
1175,1175,MS4A2,0.0002459650889024,AD,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05
1178,1178,SLC9A8,0.0002442894802389,ALS,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05
1178,1178,SLC9A8,0.0002442894802389,MS,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05
1179,1179,PSEN1,0.0002442894802389,AD,ENSG00000080815,Tier 1,PSEN1,14,73603126.0,73690399.0,1.0,presenilin 1 [Source:HGNC Symbol;Acc:9508],0.0,1.0,0.6,0.6
1179,1179,PSEN1,0.0002442894802389,FrontotemporalDementia,ENSG00000080815,Tier 1,PSEN1,14,73603126.0,73690399.0,1.0,presenilin 1 [Source:HGNC Symbol;Acc:9508],0.0,1.0,0.6,0.6
1180,1180,TLR9,0.0002442894802389,Schizophrenia,ENSG00000239732,Tier 1,TLR9,3,52255096.0,52273183.0,-1.0,toll-like receptor 9 [Source:HGNC Symbol;Acc:15633],6.0,1.0,1.0,0.6
1181,1181,CHI3L1,0.0002442894802389,Schizophrenia,ENSG00000133048,Tier 3A,CHI3L1,1,203148059.0,203155877.0,-1.0,chitinase 3-like 1 (cartilage glycoprotein-39) [Source:HGNC Symbol;Acc:1932],0.0,0.6,1.0,0.6
1192,1192,PIK3C2A,0.0002408403964281,BipolarDisorder,ENSG00000011405,Tier 2,PIK3C2A,11,17099277.0,17229530.0,-1.0,"phosphatidylinositol-4-phosphate 3-kinase, catalytic subunit type 2 alpha [Source:HGNC Symbol;Acc:8971]",3.0,1.0,0.6,0.6
1192,1192,PIK3C2A,0.0002408403964281,Schizophrenia,ENSG00000011405,Tier 2,PIK3C2A,11,17099277.0,17229530.0,-1.0,"phosphatidylinositol-4-phosphate 3-kinase, catalytic subunit type 2 alpha [Source:HGNC Symbol;Acc:8971]",3.0,1.0,0.6,0.6
1194,1194,TYR,0.0002407528717437,UnipolarDepression,ENSG00000077498,Tier 1,TYR,11,88910620.0,89028927.0,1.0,tyrosinase [Source:HGNC Symbol;Acc:12442],11.0,1.0,0.6,0.6
1195,1195,SCNN1A,0.0002407528717437,MS,ENSG00000111319,Tier 1,SCNN1A,12,6456009.0,6486896.0,-1.0,"sodium channel, non-voltage-gated 1 alpha subunit [Source:HGNC Symbol;Acc:10599]",0.0,1.0,1.0,0.6
1208,1208,LYVE1,0.0002383094977347,MigraineDisorder,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05
1208,1208,LYVE1,0.0002383094977347,MigraineWithAura,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05
1211,1211,ATP2B1,0.0002378568331165,BrainAneurysm,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05
1212,1212,GPR75,0.0002375156026717,AnorexiaNervosa,ENSG00000119737,Tier 3B,GPR75,2,54080050.0,54087126.0,-1.0,G protein-coupled receptor 75 [Source:HGNC Symbol;Acc:4526],0.0,1.0,0.6,0.6
1219,1219,SRPK2,0.0002348561113905,AnorexiaNervosa,ENSG00000135250,Tier 1,SRPK2,7,104751151.0,105039755.0,-1.0,SRSF protein kinase 2 [Source:HGNC Symbol;Acc:11306],1.0,1.0,0.6,0.6
1219,1219,SRPK2,0.0002348561113905,BipolarDisorder,ENSG00000135250,Tier 1,SRPK2,7,104751151.0,105039755.0,-1.0,SRSF protein kinase 2 [Source:HGNC Symbol;Acc:11306],1.0,1.0,0.6,0.6
1219,1219,SRPK2,0.0002348561113905,OCD,ENSG00000135250,Tier 1,SRPK2,7,104751151.0,105039755.0,-1.0,SRSF protein kinase 2 [Source:HGNC Symbol;Acc:11306],1.0,1.0,0.6,0.6
1219,1219,SRPK2,0.0002348561113905,Schizophrenia,ENSG00000135250,Tier 1,SRPK2,7,104751151.0,105039755.0,-1.0,SRSF protein kinase 2 [Source:HGNC Symbol;Acc:11306],1.0,1.0,0.6,0.6
1219,1219,SRPK2,0.0002348561113905,TouretteSyndrome,ENSG00000135250,Tier 1,SRPK2,7,104751151.0,105039755.0,-1.0,SRSF protein kinase 2 [Source:HGNC Symbol;Acc:11306],1.0,1.0,0.6,0.6
1219,1219,SRPK2,0.0002348561113905,UnipolarDepression,ENSG00000135250,Tier 1,SRPK2,7,104751151.0,105039755.0,-1.0,SRSF protein kinase 2 [Source:HGNC Symbol;Acc:11306],1.0,1.0,0.6,0.6
1220,1220,KDM3B,0.0002348561113905,AnorexiaNervosa,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05
1220,1220,KDM3B,0.0002348561113905,BipolarDisorder,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05
1220,1220,KDM3B,0.0002348561113905,OCD,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05
1220,1220,KDM3B,0.0002348561113905,Schizophrenia,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05
1220,1220,KDM3B,0.0002348561113905,TouretteSyndrome,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05
1220,1220,KDM3B,0.0002348561113905,UnipolarDepression,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05
1221,1221,PKN2,0.0002348561113905,OCD,ENSG00000065243,Tier 1,PKN2,1,89149905.0,89301938.0,1.0,protein kinase N2 [Source:HGNC Symbol;Acc:9406],2.0,1.0,0.6,0.6
1231,1231,ETV5,0.0002341341050493,BipolarDisorder,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05
1234,1234,DYRK1A,0.0002337822671219,PD,ENSG00000157540,Tier 1,DYRK1A,21,38738092.0,38889753.0,1.0,dual-specificity tyrosine-(Y)-phosphorylation regulated kinase 1A [Source:HGNC Symbol;Acc:3091],0.0,1.0,0.6,0.6
1236,1236,CHRM2,0.0002337822671219,MajorDepressiveDisorder,ENSG00000181072,Tier 1,CHRM2,7,136553416.0,136705002.0,1.0,"cholinergic receptor, muscarinic 2 [Source:HGNC Symbol;Acc:1951]",1.0,1.0,1.0,0.6
1236,1236,CHRM2,0.0002337822671219,UnipolarDepression,ENSG00000181072,Tier 1,CHRM2,7,136553416.0,136705002.0,1.0,"cholinergic receptor, muscarinic 2 [Source:HGNC Symbol;Acc:1951]",1.0,1.0,1.0,0.6
1237,1237,CILK1,0.0002337822671219,PartialEpilepsy,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05
1238,1238,CHRM4,0.0002337822671219,Schizophrenia,ENSG00000180720,Tier 1,CHRM4,11,46406640.0,46408107.0,-1.0,"cholinergic receptor, muscarinic 4 [Source:HGNC Symbol;Acc:1953]",0.0,1.0,1.0,0.6
1243,1243,AKT3,0.0002305295535396,AnorexiaNervosa,ENSG00000117020,Tier 1,AKT3,1,243651535.0,244014381.0,-1.0,v-akt murine thymoma viral oncogene homolog 3 [Source:HGNC Symbol;Acc:393],1.0,1.0,0.6,0.6
1243,1243,AKT3,0.0002305295535396,Schizophrenia,ENSG00000117020,Tier 1,AKT3,1,243651535.0,244014381.0,-1.0,v-akt murine thymoma viral oncogene homolog 3 [Source:HGNC Symbol;Acc:393],1.0,1.0,0.6,0.6
1248,1248,PTGER4,0.0002278190359408,MS,ENSG00000171522,Tier 1,PTGER4,5,40679600.0,40693837.0,1.0,prostaglandin E receptor 4 (subtype EP4) [Source:HGNC Symbol;Acc:9596],1.0,1.0,0.6,0.6
1252,1252,LTBP3,0.0002221440876437,UnipolarDepression,ENSG00000168056,Tier 3A,LTBP3,11,65306276.0,65326401.0,-1.0,latent transforming growth factor beta binding protein 3 [Source:HGNC Symbol;Acc:6716],3.0,0.6,1.0,0.6
